CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | diclofenac |
|
Accession: | CHEBI:47381
|
browse the term
|
Definition: | A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position. |
Synonyms: | exact_synonym: | {2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid |
| related_synonym: | 2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID; Formula=C14H11Cl2NO2; InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19); InChIKey=DCOPUUMXTXDBNB-UHFFFAOYSA-N; SMILES=C1(Cl)=CC=CC(=C1NC2=CC=CC=C2CC(=O)O)Cl; [2-(2,6-dichloroanilino)phenyl]acetic acid; diclofenac acid; diclofenaco; diclofenacum; diclofenamic acid |
| alt_id: | CHEBI:4507; CHEBI:47380 |
| xref: | CAS:15307-86-5; DrugBank:DB00586; Drug_Central:865; HMDB:HMDB0014724; KEGG:C01690; KEGG:D07816; LINCS:LSM-2160 |
| xref_mesh: | MESH:D004008 |
| xref: | PDBeChem:DIF; PMID:11322639; PMID:1502708; PMID:23777257; PMID:27967303; PMID:7838674; Patent:NL6604752; Patent:US3558690; Reaxys:2146636; VSDB:1933; Wikipedia:Diclofenac |
| cyclic_relationship: | is_conjugate_acid_of CHEBI:48311 |
|
|
|
G |
A2M |
alpha-2-macroglobulin |
increases expression |
ISO |
Diclofenac results in increased expression of A2M mRNA; Diclofenac results in increased expression of A2ML1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
|
|
G |
AACS |
acetoacetyl-CoA synthetase |
decreases expression |
ISO |
Diclofenac results in decreased expression of AACS mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:125,065,435...125,143,316
Ensembl chr12:125,065,434...125,143,333
|
|
G |
AARS1 |
alanyl-tRNA synthetase 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of AARS1 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr16:70,252,298...70,289,506
Ensembl chr16:70,251,983...70,289,707
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
decreases activity decreases response to substance increases expression |
ISO EXP |
Diclofenac results in decreased activity of ABCB1A protein ABCB1A gene mutant form results in decreased susceptibility to Diclofenac Diclofenac results in increased expression of ABCB1B mRNA |
CTD |
PMID:15458769 PMID:19022234 PMID:28193520 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
multiple interactions decreases activity |
EXP |
Diclofenac inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Diclofenac results in decreased activity of ABCB11 protein |
CTD |
PMID:24014644 PMID:28437613 |
|
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ABCB4 |
ATP binding cassette subfamily B member 4 |
decreases expression decreases activity |
EXP |
Diclofenac results in decreased expression of ABCB4 mRNA Diclofenac results in decreased activity of ABCB4 protein |
CTD |
PMID:19022234 PMID:28437613 |
|
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
decreases activity increases expression multiple interactions |
EXP ISO |
Diclofenac results in decreased activity of ABCC2 protein Diclofenac results in increased expression of ABCC2 mRNA ABCC2 protein results in increased transport of and results in increased metabolism of and results in increased susceptibility to Diclofenac |
CTD |
PMID:19022234 PMID:22646477 PMID:25450747 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABCC4 |
ATP binding cassette subfamily C member 4 (PEL blood group) |
affects expression |
EXP |
Diclofenac affects the expression of ABCC4 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
|
|
G |
ABL2 |
ABL proto-oncogene 2, non-receptor tyrosine kinase |
affects expression |
EXP |
Diclofenac affects the expression of ABL2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:179,099,330...179,229,677
Ensembl chr 1:179,099,330...179,229,684
|
|
G |
ACE2 |
angiotensin converting enzyme 2 |
decreases expression |
EXP |
Diclofenac results in decreased expression of ACE2 mRNA |
CTD |
PMID:32808185 |
|
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
|
|
G |
ACIN1 |
apoptotic chromatin condensation inducer 1 |
affects expression |
EXP |
Diclofenac affects the expression of ACIN1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr14:23,058,564...23,095,614
Ensembl chr14:23,058,564...23,095,614
|
|
G |
ACKR3 |
atypical chemokine receptor 3 |
decreases expression |
EXP |
Diclofenac results in decreased expression of ACKR3 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 2:236,537,122...236,582,354
Ensembl chr 2:236,567,787...236,582,354
|
|
G |
ACOT2 |
acyl-CoA thioesterase 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of ACOT2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr14:73,567,620...73,575,658
Ensembl chr14:73,567,620...73,575,658
|
|
G |
ACOX1 |
acyl-CoA oxidase 1 |
increases expression |
ISO |
Diclofenac results in increased expression of ACOX1 mRNA |
CTD |
PMID:19022234 |
|
NCBI chr17:75,941,507...75,979,166
Ensembl chr17:75,941,507...75,979,177
|
|
G |
ACP3 |
acid phosphatase 3 |
increases expression |
ISO |
Diclofenac results in increased expression of ACP3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:132,317,407...132,368,302
Ensembl chr 3:132,317,369...132,368,302
|
|
G |
ACTA1 |
actin alpha 1, skeletal muscle |
affects expression |
EXP |
Diclofenac affects the expression of ACTA1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:229,431,245...229,434,094
Ensembl chr 1:229,430,365...229,434,104
|
|
G |
ACTL9 |
actin like 9 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of ACTL9 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr19:8,697,400...8,698,795
Ensembl chr19:8,697,400...8,698,795
|
|
G |
ACTN1 |
actinin alpha 1 |
affects expression |
ISO |
Diclofenac affects the expression of ACTN1 mRNA |
CTD |
PMID:19022234 |
|
NCBI chr14:68,874,128...68,979,302
Ensembl chr14:68,874,123...68,979,440
|
|
G |
ACVR1 |
activin A receptor type 1 |
affects expression |
EXP |
Diclofenac affects the expression of ACVR1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:157,736,446...157,876,330
Ensembl chr 2:157,736,251...157,876,330
|
|
G |
ACVR1B |
activin A receptor type 1B |
affects expression multiple interactions |
EXP ISO |
Diclofenac affects the expression of ACVR1B mRNA [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of ACVR1B mRNA |
CTD |
PMID:24752500 PMID:37844793 |
|
NCBI chr12:51,951,699...51,997,078
Ensembl chr12:51,951,699...51,997,078
|
|
G |
ACVR2B |
activin A receptor type 2B |
affects expression |
EXP |
Diclofenac affects the expression of ACVR2B mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 3:38,453,890...38,493,142
Ensembl chr 3:38,453,890...38,493,142
|
|
G |
ADAMDEC1 |
ADAM like decysin 1 |
increases expression |
ISO |
Diclofenac results in increased expression of ADAMDEC1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 8:24,384,285...24,406,013
Ensembl chr 8:24,384,285...24,406,013
|
|
G |
ADCY6 |
adenylate cyclase 6 |
affects expression |
EXP |
Diclofenac affects the expression of ADCY6 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr12:48,766,194...48,789,974
Ensembl chr12:48,766,194...48,789,089
|
|
G |
ADCY9 |
adenylate cyclase 9 |
affects expression decreases expression |
EXP ISO |
Diclofenac affects the expression of ADCY9 mRNA Diclofenac results in decreased expression of ADCY9 mRNA |
CTD |
PMID:24752500 PMID:26934552 |
|
NCBI chr16:3,953,387...4,116,442
Ensembl chr16:3,953,387...4,116,442
|
|
G |
ADH1C |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
increases expression |
ISO |
Diclofenac results in increased expression of ADH1 protein |
CTD |
PMID:25772430 |
|
NCBI chr 4:99,336,497...99,352,746
Ensembl chr 4:99,336,497...99,352,746
|
|
G |
ADH7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
decreases expression |
ISO |
Diclofenac results in decreased expression of ADH7 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 4:99,412,263...99,435,342
Ensembl chr 4:99,412,261...99,435,510
|
|
G |
ADK |
adenosine kinase |
increases expression decreases expression |
EXP ISO |
Diclofenac results in increased expression of ADK mRNA Diclofenac results in decreased expression of ADK mRNA |
CTD |
PMID:19022234 |
|
NCBI chr10:74,151,221...74,709,290
Ensembl chr10:74,151,202...74,709,963
|
|
G |
ADORA2A |
adenosine A2a receptor |
increases expression |
ISO |
Diclofenac results in increased expression of ADORA2A mRNA |
CTD |
PMID:26934552 |
|
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
|
|
G |
ADORA2B |
adenosine A2b receptor |
increases expression |
ISO |
Diclofenac results in increased expression of ADORA2B mRNA |
CTD |
PMID:26934552 |
|
NCBI chr17:15,850,362...15,975,746
Ensembl chr17:15,945,130...15,975,746
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
increases expression |
ISO |
Diclofenac results in increased expression of ADRB2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
|
|
G |
AEN |
apoptosis enhancing nuclease |
increases expression |
ISO |
Diclofenac results in increased expression of AEN mRNA |
CTD |
PMID:35537566 |
|
NCBI chr15:88,604,683...88,632,281
Ensembl chr15:88,621,337...88,632,281
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
increases expression |
ISO EXP |
Diclofenac results in increased expression of AGER mRNA |
CTD |
PMID:24747151 PMID:28138970 |
|
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
|
|
G |
AGGF1 |
angiogenic factor with G-patch and FHA domains 1 |
affects expression |
EXP |
Diclofenac affects the expression of AGGF1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 5:77,030,404...77,065,234
Ensembl chr 5:77,029,251...77,065,234
|
|
G |
AGO2 |
argonaute RISC catalytic component 2 |
affects expression |
EXP |
Diclofenac affects the expression of AGO2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 8:140,520,156...140,642,313
Ensembl chr 8:140,520,156...140,635,633
|
|
G |
AGO3 |
argonaute RISC catalytic component 3 |
affects expression |
EXP |
Diclofenac affects the expression of AGO3 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:35,930,718...36,072,500
Ensembl chr 1:35,930,718...36,072,500
|
|
G |
AGO4 |
argonaute RISC component 4 |
affects expression |
EXP |
Diclofenac affects the expression of AGO4 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:35,807,636...35,857,890
Ensembl chr 1:35,808,016...35,857,890
|
|
G |
AGRP |
agouti related neuropeptide |
increases expression |
ISO |
Diclofenac results in increased expression of AGRP mRNA |
CTD |
PMID:30723492 |
|
NCBI chr16:67,482,571...67,483,547
Ensembl chr16:67,482,571...67,483,547
|
|
G |
AHR |
aryl hydrocarbon receptor |
increases expression |
ISO |
Diclofenac results in increased expression of AHR mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AHSG |
alpha 2-HS glycoprotein |
multiple interactions |
ISO |
[Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of AHSG protein |
CTD |
PMID:25772430 |
|
NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
affects expression |
EXP |
Diclofenac affects the expression of AIFM1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
AIM2 |
absent in melanoma 2 |
increases expression |
ISO |
Diclofenac results in increased expression of AIM2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:159,055,051...159,147,132
Ensembl chr 1:159,056,129...159,187,843
|
|
G |
AKNA |
AT-hook transcription factor |
decreases expression |
ISO |
Diclofenac results in decreased expression of AKNA mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 9:114,330,504...114,398,472
Ensembl chr 9:114,334,156...114,394,405
|
|
G |
AKR1B15 |
aldo-keto reductase family 1 member B15 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of AKR1B7 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 7:134,549,110...134,579,869
Ensembl chr 7:134,549,110...134,579,875
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
affects expression |
EXP |
Diclofenac affects the expression of AKT1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
AKT2 |
AKT serine/threonine kinase 2 |
affects expression |
EXP |
Diclofenac affects the expression of AKT2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr19:40,230,317...40,285,345
Ensembl chr19:40,230,317...40,285,536
|
|
G |
ALAS1 |
5'-aminolevulinate synthase 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of ALAS1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:52,198,083...52,214,327
Ensembl chr 3:52,198,086...52,214,327
|
|
G |
ALAS2 |
5'-aminolevulinate synthase 2 |
affects expression |
EXP |
Diclofenac affects the expression of ALAS2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr X:55,009,055...55,030,977
Ensembl chr X:55,009,055...55,030,977
|
|
G |
ALB |
albumin |
affects binding decreases secretion multiple interactions decreases expression increases expression |
EXP ISO |
Diclofenac binds to ALB protein Diclofenac results in decreased secretion of ALB protein [Ranitidine co-treated with Diclofenac] results in decreased expression of ALB protein; Quercetin inhibits the reaction [[Ranitidine co-treated with Diclofenac] results in decreased expression of ALB protein] Diclofenac results in decreased expression of ALB protein Diclofenac results in increased expression of ALB mRNA |
CTD |
PMID:9353694 PMID:19022234 PMID:28400101 PMID:36442613 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ALDH18A1 |
aldehyde dehydrogenase 18 family member A1 |
increases expression decreases expression |
ISO |
Diclofenac results in increased expression of ALDH18A1 mRNA Diclofenac results in decreased expression of ALDH18A1 mRNA |
CTD |
PMID:26934552 PMID:35537566 |
|
NCBI chr10:95,605,941...95,656,711
Ensembl chr10:95,605,941...95,656,711
|
|
G |
ALDH1B1 |
aldehyde dehydrogenase 1 family member B1 |
increases expression |
ISO |
Diclofenac results in increased expression of ALDH1B1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 9:38,392,702...38,398,661
Ensembl chr 9:38,392,702...38,398,661
|
|
G |
ALDH1L2 |
aldehyde dehydrogenase 1 family member L2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of ALDH1L2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:105,019,790...105,084,458
Ensembl chr12:105,019,784...105,107,643
|
|
G |
ALDH3A2 |
aldehyde dehydrogenase 3 family member A2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of ALDH3A2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760
|
|
G |
ALDOC |
aldolase, fructose-bisphosphate C |
increases expression |
ISO |
Diclofenac results in increased expression of ALDOC mRNA |
CTD |
PMID:30723492 |
|
NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948
|
|
G |
ALOX15 |
arachidonate 15-lipoxygenase |
increases expression multiple interactions |
ISO |
Diclofenac results in increased expression of ALOX15 mRNA [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of ALOX15 mRNA |
CTD |
PMID:23939143 PMID:37844793 |
|
NCBI chr17:4,630,919...4,641,678
Ensembl chr17:4,630,919...4,642,294
|
|
G |
AMH |
anti-Mullerian hormone |
increases expression multiple interactions |
ISO |
Diclofenac results in increased expression of AMH mRNA [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of AMH mRNA |
CTD |
PMID:35537566 PMID:37844793 |
|
NCBI chr19:2,249,323...2,252,073
Ensembl chr19:2,249,309...2,252,073
|
|
G |
AMOTL2 |
angiomotin like 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of AMOTL2 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 3:134,355,345...134,375,417
Ensembl chr 3:134,355,347...134,375,479
|
|
G |
ANG |
angiogenin |
increases expression |
ISO |
Diclofenac results in increased expression of ANG mRNA |
CTD |
PMID:26934552 |
|
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
|
|
G |
ANXA8 |
annexin A8 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of ANXA8 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr10:47,467,993...47,991,796
Ensembl chr10:47,460,162...47,484,158
|
|
G |
AOC3 |
amine oxidase copper containing 3 |
decreases expression |
ISO |
Diclofenac results in decreased expression of AOC3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr17:42,851,199...42,858,124
Ensembl chr17:42,851,184...42,858,130
|
|
G |
APAF1 |
apoptotic peptidase activating factor 1 |
affects expression |
EXP |
Diclofenac affects the expression of APAF1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,149...98,735,433
|
|
G |
APCS |
amyloid P component, serum |
multiple interactions increases expression |
ISO |
[Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of APCS protein Diclofenac results in increased expression of APCS mRNA; Diclofenac results in increased expression of APCS protein |
CTD |
PMID:25772430 PMID:26934552 |
|
NCBI chr 1:159,587,826...159,588,865
Ensembl chr 1:159,587,826...159,588,865
|
|
G |
APOA4 |
apolipoprotein A4 |
affects expression |
ISO |
Diclofenac affects the expression of APOA4 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
|
|
G |
AQP2 |
aquaporin 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of AQP2 protein |
CTD |
PMID:15579502 |
|
NCBI chr12:49,950,737...49,958,878
Ensembl chr12:49,950,737...49,958,878
|
|
G |
AQP9 |
aquaporin 9 |
decreases expression |
ISO |
Diclofenac results in decreased expression of AQP9 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr15:58,138,169...58,185,911
Ensembl chr15:58,138,169...58,185,911
|
|
G |
AQR |
aquarius intron-binding spliceosomal factor |
affects expression |
EXP |
Diclofenac affects the expression of AQR mRNA |
CTD |
PMID:24752500 |
|
NCBI chr15:34,851,782...34,969,742
Ensembl chr15:34,851,782...34,969,742
|
|
G |
AR |
androgen receptor |
affects activity |
EXP |
Diclofenac affects the activity of AR protein |
CTD |
PMID:29777833 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
ARAF |
A-Raf proto-oncogene, serine/threonine kinase |
affects expression |
EXP |
Diclofenac affects the expression of ARAF mRNA |
CTD |
PMID:24752500 |
|
NCBI chr X:47,561,205...47,571,908
Ensembl chr X:47,561,205...47,571,908
|
|
G |
ARHGAP20 |
Rho GTPase activating protein 20 |
increases expression |
ISO |
Diclofenac results in increased expression of ARHGAP20 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr11:110,577,043...110,713,189
Ensembl chr11:110,577,042...110,713,189
|
|
G |
ARHGAP26 |
Rho GTPase activating protein 26 |
affects expression |
EXP |
Diclofenac affects the expression of ARHGAP26 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 5:142,770,377...143,229,011
Ensembl chr 5:142,770,377...143,229,011
|
|
G |
ARHGEF2 |
Rho/Rac guanine nucleotide exchange factor 2 |
affects expression |
EXP |
Diclofenac affects the expression of ARHGEF2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:155,946,854...155,979,617
Ensembl chr 1:155,946,851...156,007,070
|
|
G |
ARHGEF3 |
Rho guanine nucleotide exchange factor 3 |
affects expression decreases expression |
EXP ISO |
Diclofenac affects the expression of ARHGEF3 mRNA Diclofenac results in decreased expression of ARHGEF3 mRNA |
CTD |
PMID:24752500 PMID:35537566 |
|
NCBI chr 3:56,727,420...57,079,268
Ensembl chr 3:56,727,418...57,079,329
|
|
G |
ARHGEF7 |
Rho guanine nucleotide exchange factor 7 |
affects expression |
EXP |
Diclofenac affects the expression of ARHGEF7 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr13:111,114,619...111,305,734
Ensembl chr13:111,114,559...111,305,737
|
|
G |
ARID4A |
AT-rich interaction domain 4A |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of ARID4A mRNA |
CTD |
PMID:37844793 |
|
NCBI chr14:58,298,555...58,373,876
Ensembl chr14:58,298,504...58,373,887
|
|
G |
ARID5A |
AT-rich interaction domain 5A |
decreases expression |
ISO |
Diclofenac results in decreased expression of ARID5A mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 2:96,536,752...96,552,638
Ensembl chr 2:96,536,743...96,552,638
|
|
G |
ARID5B |
AT-rich interaction domain 5B |
decreases expression |
ISO |
Diclofenac results in decreased expression of ARID5B mRNA |
CTD |
PMID:26934552 |
|
NCBI chr10:61,901,699...62,096,944
Ensembl chr10:61,901,684...62,096,944
|
|
G |
ARL11 |
ARF like GTPase 11 |
decreases expression |
ISO |
Diclofenac results in decreased expression of ARL11 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr13:49,628,507...49,633,872
Ensembl chr13:49,628,507...49,633,872
|
|
G |
ARMCX1 |
armadillo repeat containing X-linked 1 |
increases expression |
ISO |
Diclofenac results in increased expression of ARMCX1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr X:101,550,547...101,554,700
Ensembl chr X:101,550,547...101,554,700
|
|
G |
ARNT |
aryl hydrocarbon receptor nuclear translocator |
affects expression |
EXP |
Diclofenac affects the expression of ARNT mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
|
|
G |
ARRB1 |
arrestin beta 1 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of ARRB1 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr11:75,260,122...75,351,661
Ensembl chr11:75,260,122...75,351,705
|
|
G |
ARRDC3 |
arrestin domain containing 3 |
increases expression |
ISO |
Diclofenac results in increased expression of ARRDC3 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 5:91,368,631...91,383,317
Ensembl chr 5:91,368,631...91,383,317
|
|
G |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
affects expression |
EXP |
Diclofenac affects the expression of ASAP1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 8:130,052,104...130,443,674
Ensembl chr 8:130,052,104...130,443,674
|
|
G |
ASH2L |
ASH2 like, histone lysine methyltransferase complex subunit |
affects expression |
EXP |
Diclofenac affects the expression of ASH2L mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 8:38,105,493...38,140,080
Ensembl chr 8:38,105,493...38,144,076
|
|
G |
ASIC1 |
acid sensing ion channel subunit 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of ASIC1 mRNA |
CTD |
PMID:11588175 |
|
NCBI chr12:50,057,596...50,083,622
Ensembl chr12:50,057,548...50,083,611
|
|
G |
ASIC2 |
acid sensing ion channel subunit 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of ASIC2 mRNA |
CTD |
PMID:11588175 |
|
NCBI chr17:33,013,087...34,156,768
Ensembl chr17:33,013,087...34,174,964
|
|
G |
ASIC3 |
acid sensing ion channel subunit 3 |
decreases expression decreases activity |
ISO |
Diclofenac results in decreased expression of ASIC3 mRNA Diclofenac results in decreased activity of ASIC3 protein |
CTD |
PMID:11588175 |
|
NCBI chr 7:151,048,292...151,052,756
Ensembl chr 7:151,048,292...151,052,756
|
|
G |
ASL |
argininosuccinate lyase |
affects expression |
EXP |
Diclofenac affects the expression of ASL mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 7:66,075,819...66,093,576
Ensembl chr 7:66,075,800...66,094,697
|
|
G |
ASNS |
asparagine synthetase (glutamine-hydrolyzing) |
decreases expression increases expression |
EXP ISO |
Diclofenac results in decreased expression of ASNS mRNA Diclofenac results in increased expression of ASNS mRNA |
CTD |
PMID:19192274 PMID:26934552 PMID:35537566 |
|
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
|
|
G |
ASS1 |
argininosuccinate synthase 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of ASS1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
|
|
G |
ATF2 |
activating transcription factor 2 |
affects expression |
EXP |
Diclofenac affects the expression of ATF2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
|
|
G |
ATF4 |
activating transcription factor 4 |
affects expression decreases expression increases expression |
EXP ISO |
Diclofenac affects the expression of ATF4 mRNA Diclofenac results in decreased expression of ATF4 mRNA Diclofenac results in increased expression of ATF4 mRNA |
CTD |
PMID:24752500 PMID:27313093 PMID:35537566 |
|
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,686
|
|
G |
ATF5 |
activating transcription factor 5 |
decreases expression |
ISO |
Diclofenac results in decreased expression of ATF5 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr19:49,928,906...49,933,935
Ensembl chr19:49,928,702...49,933,935
|
|
G |
ATP11A |
ATPase phospholipid transporting 11A |
increases expression |
ISO |
Diclofenac results in increased expression of ATP11A mRNA |
CTD |
PMID:26934552 |
|
NCBI chr13:112,690,038...112,887,168
Ensembl chr13:112,690,038...112,887,168
|
|
G |
ATP5F1A |
ATP synthase F1 subunit alpha |
multiple interactions increases expression |
ISO |
[Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ATP5F1A protein Diclofenac results in increased expression of ATP5F1A protein |
CTD |
PMID:25772430 |
|
NCBI chr18:46,080,248...46,104,227
Ensembl chr18:46,080,248...46,104,334
|
|
G |
ATP5F1B |
ATP synthase F1 subunit beta |
multiple interactions increases expression |
ISO |
[Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ATP5F1B protein Diclofenac results in increased expression of ATP5F1B protein |
CTD |
PMID:25772430 |
|
NCBI chr12:56,638,175...56,645,984
Ensembl chr12:56,638,175...56,645,984
|
|
G |
ATP5PF |
ATP synthase peripheral stalk subunit F6 |
multiple interactions increases expression |
ISO |
[Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ATP5PF protein Diclofenac results in increased expression of ATP5PF protein |
CTD |
PMID:25772430 |
|
NCBI chr21:25,724,500...25,735,653
Ensembl chr21:25,716,503...25,735,673
|
|
G |
AURKAIP1 |
aurora kinase A interacting protein 1 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of AURKAIP1 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 1:1,373,736...1,375,207
Ensembl chr 1:1,373,730...1,375,207
|
|
G |
AZIN1 |
antizyme inhibitor 1 |
affects expression |
EXP |
Diclofenac affects the expression of AZIN1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 8:102,826,302...102,864,200
Ensembl chr 8:102,826,111...102,893,864
|
|
G |
B3GALT1 |
beta-1,3-galactosyltransferase 1 |
increases expression |
ISO |
Diclofenac results in increased expression of B3GALT1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 2:167,293,001...167,874,045
Ensembl chr 2:167,293,001...167,874,045
|
|
G |
BACH1 |
BTB domain and CNC homolog 1 |
affects expression |
EXP |
Diclofenac affects the expression of BACH1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr21:29,298,922...29,361,894
Ensembl chr21:29,194,071...29,630,751
|
|
G |
BAK1 |
BCL2 antagonist/killer 1 |
increases activity |
EXP |
Diclofenac results in increased activity of BAK1 protein |
CTD |
PMID:18191430 |
|
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
|
|
G |
BARD1 |
BRCA1 associated RING domain 1 |
affects expression |
EXP |
Diclofenac affects the expression of BARD1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:214,725,646...214,809,683
Ensembl chr 2:214,725,646...214,809,683
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases activity increases expression affects localization |
EXP ISO |
Diclofenac results in increased activity of BAX protein Diclofenac results in increased expression of BAX mRNA Diclofenac affects the localization of BAX protein |
CTD |
PMID:18191430 PMID:29027214 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCAR3 |
BCAR3 adaptor protein, NSP family member |
decreases expression |
ISO |
Diclofenac results in decreased expression of BCAR3 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 1:93,561,741...93,848,151
Ensembl chr 1:93,561,741...93,847,150
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
increases expression |
EXP ISO |
Diclofenac results in increased expression of BCL2 mRNA |
CTD |
PMID:29027214 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2A1 |
BCL2 related protein A1 |
decreases expression |
EXP |
Diclofenac results in decreased expression of BCL2A1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr15:79,960,892...79,971,196
Ensembl chr15:79,960,892...79,971,196
|
|
G |
BCL2L1 |
BCL2 like 1 |
increases expression affects expression |
EXP |
Diclofenac results in increased expression of BCL2L1 mRNA alternative form Diclofenac affects the expression of BCL2L1 mRNA |
CTD |
PMID:14609740 PMID:24752500 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BCL2L11 |
BCL2 like 11 |
affects expression |
EXP |
Diclofenac affects the expression of BCL2L11 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
|
|
G |
BCL3 |
BCL3 transcription coactivator |
increases expression |
ISO |
Diclofenac results in increased expression of BCL3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr19:44,747,705...44,760,044
Ensembl chr19:44,747,705...44,760,044
|
|
G |
BCL6 |
BCL6 transcription repressor |
decreases expression |
ISO |
Diclofenac results in decreased expression of BCL6 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:187,721,377...187,745,468
Ensembl chr 3:187,721,377...187,745,725
|
|
G |
BDH1 |
3-hydroxybutyrate dehydrogenase 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of BDH1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323
|
|
G |
BID |
BH3 interacting domain death agonist |
multiple interactions affects expression increases activity |
EXP |
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Diclofenac results in increased activity of BID protein] Diclofenac affects the expression of BID mRNA |
CTD |
PMID:18191430 PMID:24752500 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
BMP4 |
bone morphogenetic protein 4 |
affects expression |
EXP |
Diclofenac affects the expression of BMP4 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
|
|
G |
BMP6 |
bone morphogenetic protein 6 |
decreases expression increases expression |
ISO EXP |
Diclofenac results in decreased expression of BMP6 mRNA Diclofenac results in increased expression of BMP6 mRNA |
CTD |
PMID:26934552 PMID:32816093 |
|
NCBI chr 6:7,726,099...7,881,728
Ensembl chr 6:7,726,099...7,881,728
|
|
G |
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
affects expression |
EXP |
Diclofenac affects the expression of BRAF mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
|
|
G |
BRCA1 |
BRCA1 DNA repair associated |
increases expression |
ISO |
Diclofenac results in increased expression of BRCA1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
|
|
G |
BRCA2 |
BRCA2 DNA repair associated |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of BRCA2 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr13:32,315,077...32,400,268
Ensembl chr13:32,315,086...32,400,268
|
|
G |
BRD3OS |
BRD3 opposite strand |
decreases expression |
ISO |
Diclofenac results in decreased expression of BRD3OS mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 9:134,025,481...134,031,587
Ensembl chr 9:134,025,481...134,034,666
|
|
G |
BRDT |
bromodomain testis associated |
decreases expression |
ISO |
Diclofenac results in decreased expression of BRDT mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 1:91,949,371...92,014,428
Ensembl chr 1:91,949,343...92,014,426
|
|
G |
BRIP1 |
BRCA1 interacting DNA helicase 1 |
affects expression |
EXP |
Diclofenac affects the expression of BRIP1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr17:61,679,139...61,863,528
Ensembl chr17:61,679,139...61,863,559
|
|
G |
BTG1 |
BTG anti-proliferation factor 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of BTG1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:92,140,278...92,145,846
Ensembl chr12:92,140,278...92,145,846
|
|
G |
C1QA |
complement C1q A chain |
increases expression |
ISO |
Diclofenac results in increased expression of C1QA mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:22,636,463...22,639,678
Ensembl chr 1:22,635,077...22,639,678
|
|
G |
C1QB |
complement C1q B chain |
increases expression |
ISO |
Diclofenac results in increased expression of C1QB mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:22,653,236...22,661,637
Ensembl chr 1:22,652,762...22,661,637
|
|
G |
C1QC |
complement C1q C chain |
increases expression |
ISO |
Diclofenac results in increased expression of C1QC mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:22,643,633...22,648,108
Ensembl chr 1:22,643,014...22,648,110
|
|
G |
C2 |
complement C2 |
increases expression |
ISO |
Diclofenac results in increased expression of C2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 6:31,897,783...31,945,672
Ensembl chr 6:31,897,785...31,945,673
|
|
G |
C4B |
complement C4B (Chido/Rodgers blood group) |
increases expression |
ISO |
Diclofenac results in increased expression of C4B mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 6:32,014,795...32,035,418
Ensembl chr 6:32,014,795...32,035,418
|
|
G |
CA1 |
carbonic anhydrase 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CAR1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 8:85,327,608...85,378,113
Ensembl chr 8:85,327,608...85,379,014
|
|
G |
CA13 |
carbonic anhydrase 13 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CAR13 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 8:85,245,458...85,284,073
Ensembl chr 8:85,220,587...85,284,073
|
|
G |
CA3 |
carbonic anhydrase 3 |
decreases expression increases secretion |
ISO |
Diclofenac results in decreased expression of CAR3 mRNA Diclofenac results in increased secretion of CAR3 protein |
CTD |
PMID:24038040 PMID:26934552 |
|
NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040
|
|
G |
CACNA1B |
calcium voltage-gated channel subunit alpha1 B |
decreases expression |
ISO |
Diclofenac results in decreased expression of CACNA1B mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 9:137,877,782...138,124,619
Ensembl chr 9:137,877,782...138,124,624
|
|
G |
CALCA |
calcitonin related polypeptide alpha |
decreases expression |
ISO |
Diclofenac results in decreased expression of CALCA mRNA |
CTD |
PMID:11588175 |
|
NCBI chr11:14,966,668...14,972,351
Ensembl chr11:14,966,622...14,972,354
|
|
G |
CALM1 |
calmodulin 1 |
affects expression |
EXP |
Diclofenac affects the expression of CALM1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr14:90,396,502...90,408,268
Ensembl chr14:90,396,502...90,408,268
|
|
G |
CALML3 |
calmodulin like 3 |
increases expression |
ISO |
Diclofenac results in increased expression of CALML3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:5,524,961...5,526,771
Ensembl chr10:5,524,961...5,526,771
|
|
G |
CALR |
calreticulin |
affects expression decreases expression |
ISO |
Diclofenac affects the expression of CALR mRNA Diclofenac results in decreased expression of CALR mRNA |
CTD |
PMID:18246545 |
|
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
|
|
G |
CAMK1D |
calcium/calmodulin dependent protein kinase ID |
increases expression |
ISO |
Diclofenac results in increased expression of CAMK1D mRNA |
CTD |
PMID:26934552 |
|
NCBI chr10:12,349,547...12,835,545
Ensembl chr10:12,349,547...12,835,545
|
|
G |
CAMK2B |
calcium/calmodulin dependent protein kinase II beta |
increases expression |
ISO |
Diclofenac results in increased expression of CAMK2B mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,210,019...44,334,577
|
|
G |
CAMP |
cathelicidin antimicrobial peptide |
increases expression |
ISO |
Diclofenac results in increased expression of CAMP mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:48,223,495...48,225,485
Ensembl chr 3:48,223,347...48,225,491
|
|
G |
CAPN10 |
calpain 10 |
affects expression |
EXP |
Diclofenac affects the expression of CAPN10 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:240,586,734...240,599,104
Ensembl chr 2:240,586,734...240,617,705
|
|
G |
CARS1 |
cysteinyl-tRNA synthetase 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CARS1 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr11:3,000,929...3,057,423
Ensembl chr11:3,000,922...3,057,613
|
|
G |
CASP1 |
caspase 1 |
multiple interactions increases cleavage |
ISO |
diacerein inhibits the reaction [Diclofenac results in increased cleavage of CASP1 protein]; Diclofenac inhibits the reaction [Freund's Adjuvant results in increased cleavage of CASP1 protein] |
CTD |
PMID:25450234 PMID:38582345 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP10 |
caspase 10 |
multiple interactions affects expression |
EXP |
[Diclofenac co-treated with Hyaluronic Acid] results in increased activity of CASP10 protein Diclofenac affects the expression of CASP10 mRNA |
CTD |
PMID:20237495 PMID:24752500 |
|
NCBI chr 2:201,183,141...201,229,406
Ensembl chr 2:201,182,872...201,229,428
|
|
G |
CASP2 |
caspase 2 |
multiple interactions affects expression |
EXP |
Diclofenac inhibits the reaction [Thapsigargin results in increased activity of CASP2 protein]; Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP2 protein] Diclofenac affects the expression of CASP2 mRNA |
CTD |
PMID:16388830 PMID:24752500 |
|
NCBI chr 7:143,288,351...143,307,696
Ensembl chr 7:143,288,215...143,307,696
|
|
G |
CASP3 |
caspase 3 |
increases activity multiple interactions |
ISO EXP |
Diclofenac results in increased activity of CASP3 protein 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[TNF protein co-treated with IFNG protein] promotes the reaction [Diclofenac results in increased activity of CASP3 protein]]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Diclofenac results in increased activity of CASP3 protein]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [IFNG protein promotes the reaction [Diclofenac results in increased activity of CASP3 protein]]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [TNF protein promotes the reaction [Diclofenac results in increased activity of CASP3 protein]]; 2-aminoethoxydiphenyl borate inhibits the reaction [[TNF protein co-treated with IFNG protein] promotes the reaction [Diclofenac results in increased activity of CASP3 protein]]; 2-aminoethoxydiphenyl borate inhibits the reaction [TNF protein promotes the reaction [Diclofenac results in increased activity of CASP3 protein]]; [TNF protein co-treated with IFNG protein] promotes the reaction [Diclofenac results in increased activity of CASP3 protein]; Diclofenac inhibits the reaction [Thapsigargin results in increased activity of CASP3 protein]; Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP3 protein]; IFNG protein promotes the reaction [Diclofenac results in increased activity of CASP3 protein]; TNF protein promotes the reaction [Diclofenac results in increased activity of CASP3 protein] 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone inhibits the reaction [Diclofenac results in increased activity of CASP3 protein]; [Water deficiency co-treated with Diclofenac] results in increased expression of CASP3 protein; alpha-Tocopherol inhibits the reaction [Diclofenac results in increased activity of CASP3 protein]; Cyclosporine inhibits the reaction [Diclofenac results in increased activity of CASP3 protein]; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of CASP3 protein]; Thiourea analog inhibits the reaction [Diclofenac results in increased activity of CASP3 protein] |
CTD |
PMID:12826271 PMID:14599462 PMID:14609740 PMID:16388830 PMID:24770551 PMID:26609140 PMID:27313093 PMID:31042592 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP6 |
caspase 6 |
affects expression |
EXP |
Diclofenac affects the expression of CASP6 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 4:109,664,388...109,709,767
Ensembl chr 4:109,688,622...109,703,583
|
|
G |
CASP8 |
caspase 8 |
increases activity affects expression multiple interactions |
ISO EXP |
Diclofenac results in increased activity of CASP8 protein Diclofenac affects the expression of CASP8 mRNA [Diclofenac co-treated with Hyaluronic Acid] results in increased activity of CASP8 protein; [TNF protein co-treated with Diclofenac] results in increased activity of CASP8 protein; Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP8 protein]; Acetylcysteine inhibits the reaction [Diclofenac results in increased activity of CASP8 protein]; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP8 protein]; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Diclofenac results in increased activity of CASP8 protein] |
CTD |
PMID:14609740 PMID:20237495 PMID:24752500 PMID:27313093 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions increases expression increases activity |
EXP ISO |
[TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein; Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Diclofenac results in increased activity of CASP9 protein]; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein]; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Diclofenac results in increased activity of CASP9 protein]; Diclofenac inhibits the reaction [Thapsigargin results in increased activity of CASP9 protein]; Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP9 protein] Diclofenac results in increased expression of CASP9 mRNA |
CTD |
PMID:14609740 PMID:16388830 PMID:25014874 PMID:27313093 PMID:29027214 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
increases activity decreases activity multiple interactions |
ISO |
Diclofenac results in increased activity of CAT protein Diclofenac results in decreased activity of CAT protein Ondansetron promotes the reaction [Diclofenac results in decreased activity of CAT protein] [Water deficiency co-treated with Diclofenac] results in decreased activity of CAT protein; Acetylcysteine inhibits the reaction [Diclofenac results in decreased activity of CAT protein]; Diclofenac inhibits the reaction [Freund's Adjuvant results in decreased activity of CAT protein]; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Diclofenac results in decreased activity of CAT protein] |
CTD |
PMID:17274466 PMID:23994749 PMID:28535741 PMID:31042592 PMID:31332906 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CBL |
Cbl proto-oncogene |
affects expression |
EXP |
Diclofenac affects the expression of CBL mRNA |
CTD |
PMID:24752500 |
|
NCBI chr11:119,206,339...119,308,149
Ensembl chr11:119,206,298...119,313,926
|
|
G |
CBR1 |
carbonyl reductase 1 |
affects expression |
EXP |
Diclofenac affects the expression of CBR1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr21:36,070,024...36,073,164
Ensembl chr21:36,069,941...36,073,166
|
|
G |
CBS |
cystathionine beta-synthase |
affects expression |
EXP |
Diclofenac affects the expression of CBS mRNA |
CTD |
PMID:24752500 |
|
NCBI chr21:43,053,191...43,076,873
Ensembl chr21:43,053,191...43,076,943
|
|
G |
CCDC137 |
coiled-coil domain containing 137 |
increases expression |
ISO |
Diclofenac results in increased expression of CCDC137 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr17:81,666,737...81,673,899
Ensembl chr17:81,666,737...81,673,904
|
|
G |
CCL15 |
C-C motif chemokine ligand 15 |
increases expression |
ISO |
Diclofenac results in increased expression of CCL6 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr17:35,997,582...36,001,553
Ensembl chr17:35,996,440...36,001,553
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions increases secretion increases expression affects expression |
ISO EXP |
[Water deficiency co-treated with Diclofenac] results in increased expression of CCL2 protein; Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of CCL2 protein] Diclofenac analog results in increased secretion of CCL2 protein SB 203580 inhibits the reaction [Diclofenac analog results in increased expression of CCL2 mRNA]; U 0126 inhibits the reaction [Diclofenac analog results in increased expression of CCL2 mRNA] Diclofenac results in increased expression of CCL2 protein Diclofenac affects the expression of CCL2 mRNA Diclofenac results in increased expression of CCL2 mRNA |
CTD |
PMID:22285467 PMID:23939143 PMID:24104198 PMID:25051504 PMID:27671914 PMID:31042592 More...
|
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL23 |
C-C motif chemokine ligand 23 |
increases expression |
ISO |
Diclofenac results in increased expression of CCL9 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr17:36,013,058...36,017,972
Ensembl chr17:36,013,056...36,017,972
|
|
G |
CCL3 |
C-C motif chemokine ligand 3 |
multiple interactions decreases expression |
ISO |
Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL3 mRNA] Diclofenac results in decreased expression of CCL3 mRNA |
CTD |
PMID:23939143 PMID:35537566 |
|
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
|
|
G |
CCN1 |
cellular communication network factor 1 |
affects expression increases expression |
EXP |
Diclofenac affects the expression of CCN1 mRNA Diclofenac results in increased expression of CCN1 mRNA |
CTD |
PMID:19192274 PMID:24752500 |
|
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
|
|
G |
CCND1 |
cyclin D1 |
multiple interactions affects expression decreases expression increases expression |
EXP ISO |
Diclofenac inhibits the reaction [TNF protein results in increased expression of CCND1 protein] Diclofenac affects the expression of CCND1 mRNA Diclofenac results in decreased expression of CCND1 mRNA Diclofenac results in increased expression of CCND1 mRNA Diclofenac results in decreased expression of CCND1 protein |
CTD |
PMID:15188006 PMID:15489888 PMID:19022234 PMID:26934552 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCND3 |
cyclin D3 |
affects expression |
EXP |
Diclofenac affects the expression of CCND3 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 6:41,934,933...42,050,035
Ensembl chr 6:41,934,934...42,050,357
|
|
G |
CCNE1 |
cyclin E1 |
affects expression |
EXP |
Diclofenac affects the expression of CCNE1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
|
|
G |
CCNE2 |
cyclin E2 |
affects expression |
EXP |
Diclofenac affects the expression of CCNE2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
|
|
G |
CCNF |
cyclin F |
affects expression |
EXP |
Diclofenac affects the expression of CCNF mRNA |
CTD |
PMID:24752500 |
|
NCBI chr16:2,429,447...2,458,854
Ensembl chr16:2,429,394...2,458,854
|
|
G |
CCNG1 |
cyclin G1 |
increases expression |
ISO |
Diclofenac results in increased expression of CCNG1 mRNA |
CTD |
PMID:19022234 |
|
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,448,199
|
|
G |
CCNH |
cyclin H |
affects expression |
EXP |
Diclofenac affects the expression of CCNH mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 5:87,311,471...87,412,930
Ensembl chr 5:87,318,416...87,413,029
|
|
G |
CCR1 |
C-C motif chemokine receptor 1 |
increases expression |
ISO |
Diclofenac results in increased expression of CCR1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
increases expression |
ISO |
Diclofenac results in increased expression of CCR5 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
|
|
G |
CD14 |
CD14 molecule |
increases expression |
ISO |
Diclofenac results in increased expression of CD14 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
CD163 |
CD163 molecule |
increases expression |
ISO |
Diclofenac results in increased expression of CD163 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:7,470,811...7,503,777
Ensembl chr12:7,470,811...7,503,893
|
|
G |
CD200R1L |
CD200 receptor 1 like |
decreases expression |
ISO |
Diclofenac results in decreased expression of CD200R4 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 3:112,815,711...112,846,864
Ensembl chr 3:112,815,709...112,846,864
|
|
G |
CD244 |
CD244 molecule |
decreases expression |
ISO |
Diclofenac results in decreased expression of CD244 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 1:160,830,160...160,862,887
Ensembl chr 1:160,830,160...160,862,887
|
|
G |
CD28 |
CD28 molecule |
increases expression |
ISO |
Diclofenac results in increased expression of CD28 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 2:203,706,482...203,738,912
Ensembl chr 2:203,706,517...203,739,756
|
|
G |
CD44 |
CD44 molecule (IN blood group) |
increases expression |
ISO |
Diclofenac results in increased expression of CD44 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
|
|
G |
CD55 |
CD55 molecule (Cromer blood group) |
increases expression |
ISO |
Diclofenac results in increased expression of CD55 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:207,321,678...207,360,966
Ensembl chr 1:207,321,519...207,386,804
|
|
G |
CD5L |
CD5 molecule like |
increases expression |
ISO |
Diclofenac results in increased expression of CD5L mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:157,827,068...157,841,808
Ensembl chr 1:157,830,911...157,898,256
|
|
G |
CD9 |
CD9 molecule |
increases expression |
ISO |
Diclofenac results in increased expression of CD9 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:6,199,946...6,238,266
Ensembl chr12:6,199,715...6,238,271
|
|
G |
CDC42EP5 |
CDC42 effector protein 5 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CDC42EP5 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr19:54,465,026...54,473,296
Ensembl chr19:54,465,026...54,473,296
|
|
G |
CDC6 |
cell division cycle 6 |
affects expression |
EXP |
Diclofenac affects the expression of CDC6 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr17:40,287,879...40,304,657
Ensembl chr17:40,287,879...40,304,657
|
|
G |
CDC7 |
cell division cycle 7 |
affects expression |
EXP |
Diclofenac affects the expression of CDC7 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:91,500,851...91,525,764
Ensembl chr 1:91,500,851...91,525,764
|
|
G |
CDCA5 |
cell division cycle associated 5 |
increases expression |
ISO |
Diclofenac results in increased expression of CDCA5 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr11:65,061,093...65,084,040
Ensembl chr11:65,066,300...65,084,164
|
|
G |
CDH1 |
cadherin 1 |
increases expression affects expression decreases expression |
EXP ISO |
Diclofenac results in increased expression of CDH1 protein Diclofenac affects the expression of CDH1 mRNA Diclofenac results in decreased expression of CDH1 mRNA |
CTD |
PMID:19022234 PMID:19628293 PMID:24752500 |
|
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
|
|
G |
CDK2 |
cyclin dependent kinase 2 |
affects expression |
EXP |
Diclofenac affects the expression of CDK2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
|
|
G |
CDK5 |
cyclin dependent kinase 5 |
affects expression |
EXP |
Diclofenac affects the expression of CDK5 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 7:151,053,815...151,057,897
Ensembl chr 7:151,053,815...151,057,897
|
|
G |
CDK5R1 |
cyclin dependent kinase 5 regulatory subunit 1 |
increases expression |
ISO |
Diclofenac results in increased expression of CDK5R1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr17:32,486,993...32,491,253
Ensembl chr17:32,486,993...32,491,253
|
|
G |
CDK6 |
cyclin dependent kinase 6 |
affects expression |
EXP |
Diclofenac affects the expression of CDK6 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
|
|
G |
CDK7 |
cyclin dependent kinase 7 |
affects expression |
EXP |
Diclofenac affects the expression of CDK7 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 5:69,234,795...69,277,430
Ensembl chr 5:69,234,795...69,277,430
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression |
EXP ISO |
Diclofenac results in increased expression of CDKN1A mRNA |
CTD |
PMID:19022234 PMID:26934552 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
affects expression |
EXP |
Diclofenac affects the expression of CDKN1B mRNA |
CTD |
PMID:24752500 |
|
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CDT1 |
chromatin licensing and DNA replication factor 1 |
affects expression |
EXP |
Diclofenac affects the expression of CDT1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr16:88,803,789...88,809,258
Ensembl chr16:88,803,789...88,809,258
|
|
G |
CEBPB |
CCAAT enhancer binding protein beta |
increases expression affects expression |
EXP ISO |
Diclofenac results in increased expression of CEBPB mRNA Diclofenac affects the expression of CEBPB mRNA |
CTD |
PMID:19022234 PMID:24752500 |
|
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,734...50,192,690
|
|
G |
CEBPG |
CCAAT enhancer binding protein gamma |
decreases expression |
ISO |
Diclofenac results in decreased expression of CEBPG mRNA |
CTD |
PMID:35537566 |
|
NCBI chr19:33,373,709...33,382,686
Ensembl chr19:33,373,685...33,382,686
|
|
G |
CEP162 |
centrosomal protein 162 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CEP162 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 6:84,124,250...84,227,643
Ensembl chr 6:84,124,241...84,227,643
|
|
G |
CERS6 |
ceramide synthase 6 |
increases expression |
ISO |
Diclofenac results in increased expression of CERS6 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 2:168,456,272...168,775,134
Ensembl chr 2:168,456,249...168,775,134
|
|
G |
CES1 |
carboxylesterase 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CES1D mRNA |
CTD |
PMID:26934552 |
|
NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
|
|
G |
CFAP97D1 |
CFAP97 domain containing 1 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of CFAP97D1 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr17:43,780,435...43,787,620
Ensembl chr17:43,780,435...43,787,620
|
|
G |
CFH |
complement factor H |
increases expression |
ISO |
Diclofenac results in increased expression of CFH mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:196,652,043...196,747,504
Ensembl chr 1:196,651,754...196,752,476
|
|
G |
CFLAR |
CASP8 and FADD like apoptosis regulator |
multiple interactions affects expression |
EXP |
[Diclofenac co-treated with Hyaluronic Acid] results in decreased expression of CFLAR protein Diclofenac affects the expression of CFLAR mRNA |
CTD |
PMID:20237495 PMID:24752500 |
|
NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
|
|
G |
CGREF1 |
cell growth regulator with EF-hand domain 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CGREF1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 2:27,099,353...27,119,128
Ensembl chr 2:27,098,889...27,119,128
|
|
G |
CHAC1 |
ChaC glutathione specific gamma-glutamylcyclotransferase 1 |
increases expression decreases expression |
ISO |
Diclofenac results in increased expression of CHAC1 mRNA Diclofenac results in decreased expression of CHAC1 mRNA |
CTD |
PMID:26934552 PMID:35537566 |
|
NCBI chr15:40,953,471...40,956,512
Ensembl chr15:40,952,962...40,956,512
|
|
G |
CHCHD1 |
coiled-coil-helix-coiled-coil-helix domain containing 1 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of CHCHD1 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr10:73,782,048...73,783,652
Ensembl chr10:73,782,047...73,783,652
|
|
G |
CHDH |
choline dehydrogenase |
affects expression |
EXP |
Diclofenac affects the expression of CHDH mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 3:53,812,335...53,846,419
Ensembl chr 3:53,812,335...53,846,419
|
|
G |
CHEK1 |
checkpoint kinase 1 |
affects expression |
EXP |
Diclofenac affects the expression of CHEK1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
|
|
G |
CHKA |
choline kinase alpha |
affects expression |
EXP |
Diclofenac affects the expression of CHKA mRNA |
CTD |
PMID:24752500 |
|
NCBI chr11:68,052,859...68,121,388
Ensembl chr11:68,052,859...68,121,444
|
|
G |
CHKB |
choline kinase beta |
affects expression |
EXP |
Diclofenac affects the expression of CHKB mRNA |
CTD |
PMID:24752500 |
|
NCBI chr22:50,578,963...50,582,849
Ensembl chr22:50,578,959...50,601,455
|
|
G |
CHL1 |
cell adhesion molecule L1 like |
increases expression |
ISO |
Diclofenac results in increased expression of CHL1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:196,763...409,417
Ensembl chr 3:196,763...409,417
|
|
G |
CHST4 |
carbohydrate sulfotransferase 4 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CHST4 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr16:71,526,120...71,538,748
Ensembl chr16:71,525,233...71,538,748
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
EXP ISO |
Diclofenac inhibits the reaction [TNF protein results in increased activity of CHUK protein] Diclofenac inhibits the reaction [Freund's Adjuvant results in increased phosphorylation of CHUK protein] |
CTD |
PMID:15489888 PMID:25935278 |
|
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
|
|
G |
CIB1 |
calcium and integrin binding 1 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of CIB1 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr15:90,229,975...90,265,759
Ensembl chr15:90,229,975...90,234,047
|
|
G |
CLEC2D |
C-type lectin domain family 2 member D |
decreases expression |
ISO |
Diclofenac results in decreased expression of CLEC2H mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:9,669,713...9,699,553
Ensembl chr12:9,664,969...9,699,553
|
|
G |
CLEC6A |
C-type lectin domain containing 6A |
increases expression |
ISO |
Diclofenac results in increased expression of CLEC4N mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:8,455,962...8,478,330
Ensembl chr12:8,455,962...8,478,330
|
|
G |
CLU |
clusterin |
increases expression multiple interactions |
ISO |
Diclofenac results in increased expression of CLU protein [Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CLU protein |
CTD |
PMID:23506792 PMID:25772430 |
|
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
|
|
G |
CMPK2 |
cytidine/uridine monophosphate kinase 2 |
affects expression |
EXP |
Diclofenac affects the expression of CMPK2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:6,840,553...6,866,635
Ensembl chr 2:6,840,570...6,866,635
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
decreases expression multiple interactions |
ISO |
Diclofenac results in decreased expression of COL3A1 mRNA [Water deficiency co-treated with Diclofenac] results in increased expression of COL3A1 protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of COL3A1 protein] |
CTD |
PMID:26934552 PMID:31042592 |
|
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
|
|
G |
COTL1 |
coactosin like F-actin binding protein 1 |
increases expression |
ISO |
Diclofenac results in increased expression of COTL1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr16:84,565,596...84,618,078
Ensembl chr16:84,565,596...84,618,078
|
|
G |
COX4I2 |
cytochrome c oxidase subunit 4I2 |
increases expression |
ISO |
Diclofenac results in increased expression of COX4I2 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr20:31,637,912...31,645,006
Ensembl chr20:31,637,912...31,645,006
|
|
G |
COX6A2 |
cytochrome c oxidase subunit 6A2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of COX6A2 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr16:31,427,731...31,428,360
Ensembl chr16:31,427,731...31,428,360
|
|
G |
CPB2 |
carboxypeptidase B2 |
increases expression |
ISO |
Diclofenac results in increased expression of CPB2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr13:46,053,186...46,105,033
Ensembl chr13:46,053,186...46,105,033
|
|
G |
CPLX1 |
complexin 1 |
increases expression |
ISO |
Diclofenac results in increased expression of CPLX1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 4:784,957...826,129
Ensembl chr 4:784,957...826,129
|
|
G |
CPLX4 |
complexin 4 |
increases expression |
ISO |
Diclofenac results in increased expression of CPLX4 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr18:59,295,402...59,318,649
Ensembl chr18:59,275,156...59,318,649
|
|
G |
CPNE8 |
copine 8 |
increases expression |
ISO |
Diclofenac results in increased expression of CPNE8 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:38,652,203...38,906,835
Ensembl chr12:38,646,822...38,907,430
|
|
G |
CPSF6 |
cleavage and polyadenylation specific factor 6 |
affects expression |
EXP |
Diclofenac affects the expression of CPSF6 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr12:69,239,569...69,274,358
Ensembl chr12:69,239,569...69,274,358
|
|
G |
CPT1A |
carnitine palmitoyltransferase 1A |
increases expression |
EXP ISO |
Diclofenac results in increased expression of CPT1A mRNA |
CTD |
PMID:19022234 |
|
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
|
|
G |
CR1L |
complement C3b/C4b receptor 1 like |
multiple interactions |
ISO |
[Water deficiency co-treated with Diclofenac] results in decreased expression of CR1L protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in decreased expression of CR1L protein] |
CTD |
PMID:31042592 |
|
NCBI chr 1:207,645,133...207,723,703
Ensembl chr 1:207,645,113...207,738,416
|
|
G |
CR2 |
complement C3d receptor 2 |
affects expression |
ISO |
Diclofenac affects the expression of CR2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:207,454,328...207,489,892
Ensembl chr 1:207,453,024...207,489,895
|
|
G |
CREB3L2 |
cAMP responsive element binding protein 3 like 2 |
increases expression |
ISO |
Diclofenac results in increased expression of CREB3L2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 7:137,874,979...138,002,086
Ensembl chr 7:137,874,979...138,002,086
|
|
G |
CREB3L4 |
cAMP responsive element binding protein 3 like 4 |
affects expression |
EXP |
Diclofenac affects the expression of CREB3L4 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:153,967,487...153,974,359
Ensembl chr 1:153,967,534...153,974,361
|
|
G |
CRP |
C-reactive protein |
multiple interactions decreases expression |
ISO EXP |
[Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CRP protein; Diclofenac inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CRP protein]; lipopolysaccharide, E coli O55-B5 inhibits the reaction [Diclofenac results in decreased expression of CRP protein] Diclofenac inhibits the reaction [TNF protein results in increased expression of CRP mRNA]; Diclofenac inhibits the reaction [TNF protein results in increased secretion of CRP protein] |
CTD |
PMID:25772430 PMID:27313093 |
|
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CRY1 |
cryptochrome circadian regulator 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CRY1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:106,991,364...107,093,549
Ensembl chr12:106,991,364...107,093,549
|
|
G |
CSF1 |
colony stimulating factor 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CSF1 mRNA |
CTD |
PMID:26934552 PMID:35537566 |
|
NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
|
|
G |
CSF1R |
colony stimulating factor 1 receptor |
increases secretion increases expression |
ISO |
Diclofenac results in increased secretion of CSF1R protein Diclofenac results in increased expression of CSF1R mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:150,053,295...150,113,365
Ensembl chr 5:150,053,291...150,113,372
|
|
G |
CSF2RB |
colony stimulating factor 2 receptor subunit beta |
increases expression |
ISO |
Diclofenac results in increased expression of CSF2RB mRNA; Diclofenac results in increased expression of CSF2RB2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr22:36,913,628...36,940,439
Ensembl chr22:36,913,628...36,940,439
|
|
G |
CSNK2A1 |
casein kinase 2 alpha 1 |
affects expression |
EXP |
Diclofenac affects the expression of CSNK2A1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr20:472,498...543,790
Ensembl chr20:472,498...543,835
|
|
G |
CSNK2A2 |
casein kinase 2 alpha 2 |
affects expression |
EXP |
Diclofenac affects the expression of CSNK2A2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr16:58,157,907...58,198,106
Ensembl chr16:58,157,907...58,198,106
|
|
G |
CSRNP3 |
cysteine and serine rich nuclear protein 3 |
increases expression |
ISO |
Diclofenac results in increased expression of CSRNP3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:165,469,698...165,689,407
Ensembl chr 2:165,469,647...165,689,407
|
|
G |
CSTF2 |
cleavage stimulation factor subunit 2 |
affects expression |
EXP |
Diclofenac affects the expression of CSTF2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr X:100,820,391...100,841,520
Ensembl chr X:100,820,391...100,841,520
|
|
G |
CSTF3 |
cleavage stimulation factor subunit 3 |
affects expression |
EXP |
Diclofenac affects the expression of CSTF3 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr11:33,084,584...33,161,480
Ensembl chr11:33,077,188...33,162,371
|
|
G |
CTBP2 |
C-terminal binding protein 2 |
affects expression |
EXP |
Diclofenac affects the expression of CTBP2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr10:124,984,317...125,162,463
Ensembl chr10:124,984,317...125,161,170
|
|
G |
CTH |
cystathionine gamma-lyase |
affects expression decreases expression |
EXP ISO |
Diclofenac affects the expression of CTH mRNA Diclofenac results in decreased expression of CTH mRNA |
CTD |
PMID:24752500 PMID:35537566 |
|
NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
increases expression |
ISO |
Diclofenac results in increased expression of CTLA4 protein |
CTD |
PMID:26934552 |
|
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
|
|
G |
CTNNB1 |
catenin beta 1 |
affects expression |
EXP |
Diclofenac affects the expression of CTNNB1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CTPS1 |
CTP synthase 1 |
affects expression |
EXP |
Diclofenac affects the expression of CTPS1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:40,979,696...41,012,565
Ensembl chr 1:40,979,300...41,012,565
|
|
G |
CTPS2 |
CTP synthase 2 |
affects expression |
EXP |
Diclofenac affects the expression of CTPS2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr X:16,587,999...16,712,910
Ensembl chr X:16,587,999...16,712,936
|
|
G |
CTSC |
cathepsin C |
increases expression |
ISO |
Diclofenac results in increased expression of CTSC mRNA |
CTD |
PMID:26934552 |
|
NCBI chr11:88,293,592...88,337,736
Ensembl chr11:88,265,069...88,359,684
|
|
G |
CTSE |
cathepsin E |
decreases expression |
ISO |
Diclofenac results in decreased expression of CTSE mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 1:206,009,264...206,023,895
Ensembl chr 1:206,008,535...206,023,909
|
|
G |
CTSS |
cathepsin S |
increases expression |
ISO |
Diclofenac results in increased expression of CTSS mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957
|
|
G |
CUL3 |
cullin 3 |
affects expression |
EXP |
Diclofenac affects the expression of CUL3 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:224,470,150...224,585,363
Ensembl chr 2:224,470,150...224,585,397
|
|
G |
CUL7 |
cullin 7 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CUL7 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 6:43,037,617...43,053,851
Ensembl chr 6:43,037,617...43,053,943
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
multiple interactions decreases expression increases expression |
ISO |
Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL1 mRNA]; Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL1 protein] Diclofenac results in decreased expression of CXCL1 mRNA Diclofenac results in increased expression of CXCL1 mRNA; Diclofenac results in increased expression of CXCL1 protein |
CTD |
PMID:23939143 PMID:26934552 PMID:27671914 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL13 |
C-X-C motif chemokine ligand 13 |
increases expression |
ISO |
Diclofenac results in increased expression of CXCL13 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 4:77,511,753...77,611,834
Ensembl chr 4:77,511,753...77,611,834
|
|
G |
CXCL14 |
C-X-C motif chemokine ligand 14 |
increases expression |
ISO |
Diclofenac results in increased expression of CXCL14 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:135,570,679...135,578,991
Ensembl chr 5:135,570,679...135,579,279
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO |
Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL2 mRNA] Diclofenac results in increased expression of CXCL2 mRNA; Diclofenac results in increased expression of CXCL2 protein |
CTD |
PMID:22285467 PMID:23939143 PMID:24747151 PMID:26934552 PMID:27671914 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
affects expression increases secretion increases expression multiple interactions decreases expression |
EXP |
Diclofenac affects the expression of CXCL8 mRNA Diclofenac analog results in increased secretion of CXCL8 protein Diclofenac analog results in increased expression of CXCL8 mRNA; Diclofenac results in increased expression of CXCL8 mRNA Diclofenac inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; Diclofenac inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein]; Diclofenac promotes the reaction [Mustard Gas results in increased secretion of CXCL8 protein]; pyrazolanthrone inhibits the reaction [Diclofenac analog results in increased expression of CXCL8 mRNA]; SB 203580 inhibits the reaction [Diclofenac analog results in increased expression of CXCL8 mRNA] Diclofenac results in decreased expression of CXCL8 mRNA; Diclofenac results in decreased expression of CXCL8 protein |
CTD |
PMID:17379860 PMID:19192274 PMID:24104198 PMID:24752500 PMID:27313093 PMID:31048000 PMID:32816093 More...
|
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CXCR4 |
C-X-C motif chemokine receptor 4 |
decreases expression |
EXP ISO |
Diclofenac results in decreased expression of CXCR4 mRNA |
CTD |
PMID:19192274 PMID:35537566 |
|
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
|
|
G |
CYB561 |
cytochrome b561 |
increases expression |
ISO |
Diclofenac results in increased expression of CYB561 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr17:63,432,304...63,446,639
Ensembl chr17:63,432,304...63,446,354
|
|
G |
CYBA |
cytochrome b-245 alpha chain |
increases expression |
ISO |
Diclofenac results in increased expression of CYBA mRNA |
CTD |
PMID:26934552 |
|
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
|
|
G |
CYBB |
cytochrome b-245 beta chain |
increases expression |
ISO |
Diclofenac results in increased expression of CYBB mRNA |
CTD |
PMID:26934552 |
|
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461
|
|
G |
CYCS |
cytochrome c, somatic |
affects expression |
EXP |
Diclofenac affects the expression of CYCS mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP17A1 |
cytochrome P450 family 17 subfamily A member 1 |
increases expression |
ISO |
Diclofenac results in increased expression of CYP17A1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
|
|
G |
CYP19A1 |
cytochrome P450 family 19 subfamily A member 1 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of CYP19A1 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases expression decreases activity |
EXP ISO |
Diclofenac results in increased expression of CYP1A1 mRNA; Diclofenac results in increased expression of CYP1A1 protein Diclofenac results in decreased activity of CYP1A1 protein |
CTD |
PMID:18420780 PMID:21784029 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
increases expression decreases activity multiple interactions |
EXP |
Diclofenac results in increased expression of CYP1A2 mRNA; Diclofenac results in increased expression of CYP1A2 protein Diclofenac metabolite results in decreased activity of CYP1A2 protein [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Diclofenac |
CTD |
PMID:21784029 PMID:23397584 PMID:28960974 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
decreases activity |
ISO |
Diclofenac results in decreased activity of CYP1B1 protein |
CTD |
PMID:18420780 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP26A1 |
cytochrome P450 family 26 subfamily A member 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CYP26A1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr10:93,073,475...93,077,885
Ensembl chr10:93,073,475...93,077,885
|
|
G |
CYP26B1 |
cytochrome P450 family 26 subfamily B member 1 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of CYP26B1 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 2:72,129,238...72,147,862
Ensembl chr 2:72,129,238...72,147,862
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
affects expression |
ISO |
Diclofenac affects the expression of CYP2A5 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
CYP2A7 |
cytochrome P450 family 2 subfamily A member 7 |
affects expression decreases activity |
ISO |
Diclofenac affects the expression of CYP2A4 mRNA Diclofenac results in decreased activity of CYP2A4 protein |
CTD |
PMID:18420780 PMID:26934552 |
|
NCBI chr19:40,875,439...40,882,231
Ensembl chr19:40,875,439...40,882,752
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
decreases activity |
ISO |
Diclofenac results in decreased activity of CYP2B10 protein |
CTD |
PMID:18420780 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
CYP2C19 |
cytochrome P450 family 2 subfamily C member 19 |
multiple interactions increases response to substance increases hydroxylation |
EXP ISO |
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Diclofenac; [CYP2C19 protein co-treated with CYP2C9 protein] results in increased hydroxylation of Diclofenac CYP2C19 protein results in increased susceptibility to Diclofenac CYP2C6 protein results in increased hydroxylation of Diclofenac CYP2C19 protein results in increased hydroxylation of Diclofenac |
CTD |
PMID:11911841 PMID:15486075 PMID:18511451 PMID:23397584 PMID:28762043 |
|
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
|
|
G |
CYP2C23P |
cytochrome P450 family 2 subfamily C member 23, pseudogene |
decreases expression |
ISO |
Diclofenac results in decreased expression of CYP2C23 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr10:100,105,754...100,140,151
Ensembl chr10:100,105,754...100,140,151
|
|
G |
CYP2C8 |
cytochrome P450 family 2 subfamily C member 8 |
decreases activity |
ISO |
Diclofenac results in decreased activity of CYP2C29 protein |
CTD |
PMID:18420780 |
|
NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
|
|
G |
CYP2C9 |
cytochrome P450 family 2 subfamily C member 9 |
decreases hydroxylation decreases activity increases hydroxylation increases metabolic processing multiple interactions increases hydrolysis affects hydrolysis increases activity increases oxidation affects binding affects metabolic processing |
EXP ISO |
CYP2C9 gene polymorphism results in decreased hydroxylation of Diclofenac Diclofenac results in decreased activity of CYP2C9 protein CYP2C9 protein results in increased hydroxylation of Diclofenac CYP2C9 mRNA results in increased metabolism of Diclofenac; CYP2C9 protein results in increased metabolism of Diclofenac 1-aminobenzotriazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac]; 4-methylimidazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; [5-bromotryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac; [5-chlorotryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac; [5-fluoro-alpha-methyltryptamine results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac; [5-fluorotryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac; [5-methyltryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac; [7-methyltryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac; [[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac; [[Ticrynafen results in decreased activity of CYP2C9 protein] which affects the metabolism of Diclofenac] which affects the abundance of 4'-hydroxydiclofenac; [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Diclofenac; [CYP2C19 protein co-treated with CYP2C9 protein] results in increased hydroxylation of Diclofenac; [CYP2C9 mRNA results in increased metabolism of Diclofenac] which results in increased chemical synthesis of 4'-hydroxydiclofenac; [CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac; [CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased metabolism of Diclofenac; [CYP2C9 protein results in increased hydroxylation of Diclofenac] which results in increased chemical synthesis of 4'-hydroxydiclofenac; [CYP2C9 protein results in increased metabolism of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac; [CYP2C9 protein results in increased metabolism of Diclofenac] which results in increased chemical synthesis of 4'-hydroxydiclofenac; [CYP3A4 protein co-treated with CYP2C9 protein co-treated with UGT2B7 protein] results in increased susceptibility to Diclofenac; [CYP3A4 protein co-treated with CYP2C9 protein] results in increased susceptibility to Diclofenac; [Fluconazole results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac; [Sulfaphenazole results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac; [Ticrynafen results in decreased activity of CYP2C9 protein] which affects the metabolism of Diclofenac; [Tryptamines analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac; Amiodarone inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; Benzbromarone inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; Clotrimazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; Cyclohexenes analog inhibits the reaction [CYP2C9 protein results in increased metabolism of Diclofenac]; CYP2C9 gene mutant form inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac]; CYP2C9 protein results in increased hydroxylation of and results in increased susceptibility to Diclofenac; Fluconazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; Fluvastatin inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; Ibuprofen inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; Ketoconazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; Lansoprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac]; methysticin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac]; Miconazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; Omeprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac]; Pantoprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac]; perfluorooctane sulfonic acid inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac]; Piroxicam inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; Quinine inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; rabeprazole-thioether inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac]; Sertraline inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; sitaxsentan inhibits the reaction [CYP2C9 protein results in increased metabolism of Diclofenac]; Sulfaphenazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased metabolism of Diclofenac]; Sulfinpyrazone inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; Ticrynafen inhibits the reaction [CYP2C9 protein results in increased metabolism of Diclofenac]; Tolbutamide inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; Warfarin inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac]; zafirlukast inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] CYP2C9 protein results in increased hydrolysis of Diclofenac CYP2C9 gene polymorphism affects the hydrolysis of Diclofenac Diclofenac results in increased activity of CYP2C9 protein CYP2C9 protein results in increased oxidation of Diclofenac CYP2C9 protein binds to Diclofenac |
CTD |
PMID:9110362 PMID:9241660 PMID:9698079 PMID:10975605 PMID:10991840 PMID:11455026 PMID:12401345 PMID:12464242 PMID:12569440 PMID:15039296 PMID:15135088 PMID:15155557 PMID:15258107 PMID:15486075 PMID:15618748 PMID:15801540 PMID:15802386 PMID:15860655 PMID:16049126 PMID:16081671 PMID:17418993 PMID:17478480 PMID:17681167 PMID:17994679 PMID:18420780 PMID:19082874 PMID:19309152 PMID:20452209 PMID:21964418 PMID:22447115 PMID:23397584 PMID:23721565 PMID:24104198 PMID:24246759 PMID:25084468 PMID:25994031 PMID:26255664 PMID:26599973 PMID:27590069 PMID:28119166 PMID:28762043 PMID:29445054 PMID:29555536 PMID:31854189 PMID:33259822 PMID:35366062 PMID:35583123 PMID:35748891 More...
|
|
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
|
|
G |
CYP2D6 |
cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene) |
multiple interactions |
EXP |
[[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac; [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Diclofenac; [CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac |
CTD |
PMID:23397584 PMID:24246759 |
|
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
decreases activity |
EXP |
Diclofenac metabolite results in decreased activity of CYP2E1 protein |
CTD |
PMID:28960974 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
CYP39A1 |
cytochrome P450 family 39 subfamily A member 1 |
increases expression |
ISO |
Diclofenac results in increased expression of CYP39A1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 6:46,549,580...46,652,818
Ensembl chr 6:46,549,580...46,652,830
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
increases expression increases response to substance increases metabolic processing multiple interactions decreases activity |
EXP |
Diclofenac results in increased expression of CYP3A4 mRNA CYP3A4 protein results in increased susceptibility to Diclofenac CYP3A4 protein results in increased metabolism of Diclofenac [[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 5-hydroxydiclofenac; [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Diclofenac; [CYP3A4 protein co-treated with CYP2C9 protein co-treated with UGT2B7 protein] results in increased susceptibility to Diclofenac; [CYP3A4 protein co-treated with CYP2C9 protein] results in increased susceptibility to Diclofenac; [CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of Diclofenac; [CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac Diclofenac metabolite results in decreased activity of CYP3A4 protein; Diclofenac results in decreased activity of CYP3A4 protein |
CTD |
PMID:15135088 PMID:19022234 PMID:23397584 PMID:24104198 PMID:24246759 PMID:28762043 PMID:28960974 PMID:29027214 PMID:33259822 More...
|
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
CYP3A5 |
cytochrome P450 family 3 subfamily A member 5 |
increases expression decreases activity |
ISO |
Diclofenac results in increased expression of CYP3A13 mRNA Diclofenac metabolite results in decreased activity of CYP3A13 protein |
CTD |
PMID:26934552 PMID:28960974 |
|
NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
|
|
G |
CYP46A1 |
cytochrome P450 family 46 subfamily A member 1 |
increases hydroxylation |
EXP |
CYP46A1 protein results in increased hydroxylation of Diclofenac |
CTD |
PMID:14640697 |
|
NCBI chr14:99,684,298...99,727,301
Ensembl chr14:99,684,298...99,727,301
|
|
G |
CYP4A11 |
cytochrome P450 family 4 subfamily A member 11 |
affects activity |
EXP |
Diclofenac affects the activity of CYP4A11 protein |
CTD |
PMID:37499995 |
|
NCBI chr 1:46,929,188...46,941,476
Ensembl chr 1:46,929,177...46,941,484
|
|
G |
CYP4A22 |
cytochrome P450 family 4 subfamily A member 22 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CYP4A31 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:47,137,441...47,149,727
Ensembl chr 1:47,137,435...47,149,727
|
|
G |
CYP4F22 |
cytochrome P450 family 4 subfamily F member 22 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CYP4F39 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr19:15,508,525...15,552,317
Ensembl chr19:15,508,525...15,552,317
|
|
G |
CYP4V2 |
cytochrome P450 family 4 subfamily V member 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CYP4V3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 4:186,191,567...186,213,463
Ensembl chr 4:186,191,567...186,213,463
|
|
G |
CYP51A1 |
cytochrome P450 family 51 subfamily A member 1 |
decreases activity increases expression |
ISO |
Diclofenac metabolite results in decreased activity of CYP51A1 protein Diclofenac results in increased expression of CYP51 mRNA |
CTD |
PMID:26934552 PMID:28960974 |
|
NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
ISO |
Diclofenac results in increased expression of CYP7A1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
CYP8B1 |
cytochrome P450 family 8 subfamily B member 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
|
|
G |
DAP |
death associated protein |
increases expression |
ISO |
Diclofenac results in increased expression of DAP mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:10,679,230...10,761,234
Ensembl chr 5:10,679,230...10,761,234
|
|
G |
DBT |
dihydrolipoamide branched chain transacylase E2 |
affects expression |
EXP |
Diclofenac affects the expression of DBT mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:100,186,919...100,249,834
Ensembl chr 1:100,186,919...100,249,834
|
|
G |
DCTPP1 |
dCTP pyrophosphatase 1 |
affects expression |
EXP |
Diclofenac affects the expression of DCTPP1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr16:30,423,615...30,430,030
Ensembl chr16:30,423,615...30,430,030
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
increases response to substance decreases expression increases expression |
ISO EXP |
DDIT3 results in increased susceptibility to Diclofenac Diclofenac results in decreased expression of DDIT3 mRNA Diclofenac results in increased expression of DDIT3 mRNA; Diclofenac results in increased expression of DDIT3 protein |
CTD |
PMID:18172885 PMID:20668000 PMID:24752500 PMID:27313093 PMID:27358234 PMID:35537566 More...
|
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DDIT4 |
DNA damage inducible transcript 4 |
increases expression |
ISO |
Diclofenac results in increased expression of DDIT4 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
|
|
G |
DDR1 |
discoidin domain receptor tyrosine kinase 1 |
affects expression |
EXP |
Diclofenac affects the expression of DDR1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 6:30,880,970...30,900,156
Ensembl chr 6:30,876,421...30,900,156
|
|
G |
DDT |
D-dopachrome tautomerase |
decreases expression |
ISO |
Diclofenac results in decreased expression of DDT mRNA |
CTD |
PMID:26934552 |
|
NCBI chr22:23,971,370...23,980,504
Ensembl chr22:23,970,542...23,980,525
|
|
G |
DDX5 |
DEAD-box helicase 5 |
affects expression |
EXP |
Diclofenac affects the expression of DDX5 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr17:64,498,254...64,506,866
Ensembl chr17:64,498,254...64,508,199
|
|
G |
DECR1 |
2,4-dienoyl-CoA reductase 1 |
increases expression |
ISO |
Diclofenac results in increased expression of DECR1 protein |
CTD |
PMID:25772430 |
|
NCBI chr 8:90,001,477...90,053,633
Ensembl chr 8:90,001,405...90,053,633
|
|
G |
DENND2D |
DENN domain containing 2D |
decreases expression |
ISO |
Diclofenac results in decreased expression of DENND2D mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 1:111,185,969...111,204,578
Ensembl chr 1:111,185,969...111,204,535
|
|
G |
DERL1 |
derlin 1 |
increases expression |
ISO |
Diclofenac results in increased expression of DERL1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 8:123,013,170...123,042,302
Ensembl chr 8:123,013,170...123,042,302
|
|
G |
DERL3 |
derlin 3 |
increases expression |
ISO |
Diclofenac results in increased expression of DERL3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr22:23,834,503...23,839,006
Ensembl chr22:23,834,503...23,839,128
|
|
G |
DFFA |
DNA fragmentation factor subunit alpha |
affects expression |
EXP |
Diclofenac affects the expression of DFFA mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:10,456,522...10,472,529
Ensembl chr 1:10,456,522...10,472,529
|
|
G |
DHCR24 |
24-dehydrocholesterol reductase |
increases expression |
ISO |
Diclofenac results in increased expression of DHCR24 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195
|
|
G |
DHFR |
dihydrofolate reductase |
affects expression |
EXP |
Diclofenac affects the expression of DHFR mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
|
|
G |
DHRS3 |
dehydrogenase/reductase 3 |
decreases expression |
ISO |
Diclofenac results in decreased expression of DHRS3 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 1:12,567,910...12,618,210
Ensembl chr 1:12,567,909...12,620,133
|
|
G |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
affects expression |
EXP |
Diclofenac affects the expression of DKK1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr10:52,314,281...52,317,657
Ensembl chr10:52,314,281...52,318,042
|
|
G |
DNAAF2 |
dynein axonemal assembly factor 2 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of DNAAF2 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr14:49,625,174...49,635,244
Ensembl chr14:49,625,174...49,635,244
|
|
G |
DNAJA1 |
DnaJ heat shock protein family (Hsp40) member A1 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJA1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 9:33,025,273...33,039,907
Ensembl chr 9:33,025,273...33,039,907
|
|
G |
DNAJA2 |
DnaJ heat shock protein family (Hsp40) member A2 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJA2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr16:46,955,362...46,973,674
Ensembl chr16:46,955,362...46,973,674
|
|
G |
DNAJA3 |
DnaJ heat shock protein family (Hsp40) member A3 |
affects expression decreases expression |
EXP ISO |
Diclofenac affects the expression of DNAJA3 mRNA Diclofenac results in decreased expression of DNAJA3 mRNA |
CTD |
PMID:24752500 PMID:26934552 |
|
NCBI chr16:4,425,868...4,456,775
Ensembl chr16:4,425,805...4,456,775
|
|
G |
DNAJB1 |
DnaJ heat shock protein family (Hsp40) member B1 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJB1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr19:14,514,769...14,560,391
Ensembl chr19:14,513,789...14,560,391
|
|
G |
DNAJB14 |
DnaJ heat shock protein family (Hsp40) member B14 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJB14 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 4:99,896,248...99,946,618
Ensembl chr 4:99,896,248...99,946,618
|
|
G |
DNAJB4 |
DnaJ heat shock protein family (Hsp40) member B4 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJB4 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
|
|
G |
DNAJB6 |
DnaJ heat shock protein family (Hsp40) member B6 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJB6 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 7:157,337,004...157,417,439
Ensembl chr 7:157,335,381...157,417,439
|
|
G |
DNAJB7 |
DnaJ heat shock protein family (Hsp40) member B7 |
increases expression |
ISO |
Diclofenac results in increased expression of DNAJB7 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr22:40,859,549...40,862,113
Ensembl chr22:40,859,549...40,862,113
|
|
G |
DNAJB9 |
DnaJ heat shock protein family (Hsp40) member B9 |
affects expression increases expression |
EXP ISO |
Diclofenac affects the expression of DNAJB9 mRNA Diclofenac results in increased expression of DNAJB9 mRNA |
CTD |
PMID:24752500 PMID:26934552 |
|
NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850
|
|
G |
DNAJC10 |
DnaJ heat shock protein family (Hsp40) member C10 |
affects expression increases expression |
EXP ISO |
Diclofenac affects the expression of DNAJC10 mRNA Diclofenac results in increased expression of DNAJC10 mRNA |
CTD |
PMID:24752500 PMID:26934552 |
|
NCBI chr 2:182,716,257...182,794,464
Ensembl chr 2:182,716,255...182,794,464
|
|
G |
DNAJC11 |
DnaJ heat shock protein family (Hsp40) member C11 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJC11 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:6,634,170...6,701,816
Ensembl chr 1:6,634,168...6,701,924
|
|
G |
DNAJC12 |
DnaJ heat shock protein family (Hsp40) member C12 |
increases expression decreases expression |
ISO |
Diclofenac results in increased expression of DNAJC12 mRNA Diclofenac results in decreased expression of DNAJC12 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr10:67,796,669...67,838,188
Ensembl chr10:67,796,669...67,838,188
|
|
G |
DNAJC15 |
DnaJ heat shock protein family (Hsp40) member C15 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJC15 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr13:43,023,586...43,114,213
Ensembl chr13:43,023,203...43,114,213
|
|
G |
DNAJC18 |
DnaJ heat shock protein family (Hsp40) member C18 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJC18 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 5:139,410,203...139,439,525
Ensembl chr 5:139,408,588...139,444,491
|
|
G |
DNAJC21 |
DnaJ heat shock protein family (Hsp40) member C21 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJC21 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 5:34,929,559...34,958,964
Ensembl chr 5:34,929,559...34,958,964
|
|
G |
DNAJC3 |
DnaJ heat shock protein family (Hsp40) member C3 |
increases expression |
ISO |
Diclofenac results in increased expression of DNAJC3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr13:95,677,139...95,794,988
Ensembl chr13:95,677,139...95,794,988
|
|
G |
DNAJC5 |
DnaJ heat shock protein family (Hsp40) member C5 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJC5 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr20:63,895,126...63,936,011
Ensembl chr20:63,895,126...63,936,031
|
|
G |
DNAJC6 |
DnaJ heat shock protein family (Hsp40) member C6 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJC6 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:65,264,749...65,415,871
Ensembl chr 1:65,248,219...65,415,871
|
|
G |
DNAJC7 |
DnaJ heat shock protein family (Hsp40) member C7 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJC7 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr17:41,976,435...42,017,439
Ensembl chr17:41,976,421...42,021,376
|
|
G |
DNAJC8 |
DnaJ heat shock protein family (Hsp40) member C8 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJC8 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:28,200,278...28,233,029
Ensembl chr 1:28,199,456...28,233,029
|
|
G |
DNAJC9 |
DnaJ heat shock protein family (Hsp40) member C9 |
affects expression |
EXP |
Diclofenac affects the expression of DNAJC9 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr10:73,232,272...73,247,255
Ensembl chr10:73,183,362...73,247,255
|
|
G |
DND1 |
DND microRNA-mediated repression inhibitor 1 |
increases expression |
ISO |
Diclofenac results in increased expression of DND1 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 5:140,670,794...140,673,576
Ensembl chr 5:140,670,794...140,673,576
|
|
G |
DNER |
delta/notch like EGF repeat containing |
decreases expression |
ISO |
Diclofenac results in decreased expression of DNER mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 2:229,357,629...229,714,555
Ensembl chr 2:229,357,629...229,714,555
|
|
G |
DPYSL2 |
dihydropyrimidinase like 2 |
affects expression |
EXP |
Diclofenac affects the expression of DPYSL2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 8:26,514,031...26,658,175
Ensembl chr 8:26,514,031...26,658,178
|
|
G |
DRD1 |
dopamine receptor D1 |
increases expression |
ISO |
Diclofenac results in increased expression of DRD1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:175,440,036...175,444,182
Ensembl chr 5:175,440,036...175,444,182
|
|
G |
DTYMK |
deoxythymidylate kinase |
affects expression |
EXP |
Diclofenac affects the expression of DTYMK mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:241,675,747...241,686,815
Ensembl chr 2:241,675,747...241,686,944
|
|
G |
DUSP1 |
dual specificity phosphatase 1 |
affects expression decreases expression |
EXP ISO |
Diclofenac affects the expression of DUSP1 mRNA Diclofenac results in decreased expression of DUSP1 mRNA |
CTD |
PMID:24752500 PMID:26934552 |
|
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
|
|
G |
DUT |
deoxyuridine triphosphatase |
affects expression |
EXP |
Diclofenac affects the expression of DUT mRNA |
CTD |
PMID:24752500 |
|
NCBI chr15:48,331,095...48,343,373
Ensembl chr15:48,331,011...48,343,373
|
|
G |
DYNC1I1 |
dynein cytoplasmic 1 intermediate chain 1 |
increases expression |
ISO |
Diclofenac results in increased expression of DYNC1I1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 7:95,772,554...96,110,322
Ensembl chr 7:95,772,506...96,110,322
|
|
G |
E2F1 |
E2F transcription factor 1 |
affects expression |
EXP |
Diclofenac affects the expression of E2F1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
|
|
G |
E2F2 |
E2F transcription factor 2 |
affects expression |
EXP |
Diclofenac affects the expression of E2F2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:23,505,212...23,531,233
Ensembl chr 1:23,506,438...23,531,233
|
|
G |
E2F5 |
E2F transcription factor 5 |
affects expression |
EXP |
Diclofenac affects the expression of E2F5 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 8:85,177,154...85,214,518
Ensembl chr 8:85,177,154...85,217,158
|
|
G |
EBLN1 |
endogenous Bornavirus like nucleoprotein 1 |
increases expression |
ISO |
Diclofenac results in increased expression of IGKV8-24 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:22,208,475...22,218,015
Ensembl chr10:22,208,475...22,218,015
|
|
G |
ECM1 |
extracellular matrix protein 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of ECM1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:150,508,109...150,513,789
Ensembl chr 1:150,508,062...150,513,789
|
|
G |
ECT2 |
epithelial cell transforming 2 |
increases expression |
ISO |
Diclofenac results in increased expression of ECT2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:172,750,726...172,829,265
Ensembl chr 3:172,750,682...172,821,474
|
|
G |
EDEM1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
increases expression |
ISO |
Diclofenac results in increased expression of EDEM1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:5,187,707...5,219,958
Ensembl chr 3:5,187,646...5,219,958
|
|
G |
EDIL3 |
EGF like repeats and discoidin domains 3 |
decreases expression |
ISO |
Diclofenac results in decreased expression of EDIL3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:83,940,554...84,384,880
Ensembl chr 5:83,940,554...84,384,880
|
|
G |
EDN1 |
endothelin 1 |
multiple interactions |
ISO |
Diclofenac inhibits the reaction [EDN1 protein results in decreased transport of Potassium] |
CTD |
PMID:15083534 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
EDN2 |
endothelin 2 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of EDN2 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 1:41,478,775...41,484,683
Ensembl chr 1:41,478,775...41,484,683
|
|
G |
EEF2K |
eukaryotic elongation factor 2 kinase |
decreases expression |
ISO |
Diclofenac results in decreased expression of EEF2K mRNA |
CTD |
PMID:35537566 |
|
NCBI chr16:22,206,278...22,288,738
Ensembl chr16:22,206,278...22,288,738
|
|
G |
EGF |
epidermal growth factor |
increases expression |
ISO |
Diclofenac results in increased expression of EGF protein |
CTD |
PMID:23506792 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
increases expression |
ISO |
Diclofenac results in increased expression of EGFR mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EGR1 |
early growth response 1 |
increases expression multiple interactions affects expression |
EXP ISO |
Diclofenac results in increased expression of EGR1 mRNA [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of EGR1 mRNA Diclofenac affects the expression of EGR1 mRNA |
CTD |
PMID:15509713 PMID:26934552 PMID:37844793 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
EIF1 |
eukaryotic translation initiation factor 1 |
affects expression |
EXP |
Diclofenac affects the expression of EIF1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr17:41,688,885...41,692,668
Ensembl chr17:41,688,885...41,692,668
|
|
G |
EIF1AX |
eukaryotic translation initiation factor 1A X-linked |
affects expression |
EXP |
Diclofenac affects the expression of EIF1AX mRNA |
CTD |
PMID:24752500 |
|
NCBI chr X:20,124,525...20,141,838
Ensembl chr X:20,124,525...20,141,838
|
|
G |
EIF2A |
eukaryotic translation initiation factor 2A |
affects expression |
EXP |
Diclofenac affects the expression of EIF2A mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 3:150,546,787...150,586,016
Ensembl chr 3:150,546,678...150,586,016
|
|
G |
EIF2AK1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
affects expression decreases expression |
EXP ISO |
Diclofenac affects the expression of EIF2AK1 mRNA Diclofenac results in decreased expression of EIF2AK1 mRNA |
CTD |
PMID:24752500 PMID:26934552 |
|
NCBI chr 7:6,022,247...6,059,175
Ensembl chr 7:6,022,247...6,059,175
|
|
G |
EIF2AK3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
affects expression increases expression increases phosphorylation multiple interactions increases activity |
EXP ISO |
Diclofenac affects the expression of EIF2AK3 mRNA Diclofenac results in increased expression of EIF2AK3 mRNA Diclofenac results in increased phosphorylation of EIF2AK3 protein 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Diclofenac results in increased phosphorylation of EIF2AK3 protein]; 2-aminoethoxydiphenyl borate inhibits the reaction [Diclofenac results in increased phosphorylation of EIF2AK3 protein]; Calcium promotes the reaction [Diclofenac results in increased phosphorylation of EIF2AK3 protein] Diclofenac results in increased activity of EIF2AK3 protein |
CTD |
PMID:24752500 PMID:26609140 PMID:26934552 |
|
NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
|
|
G |
EIF2AK4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
affects expression |
EXP |
Diclofenac affects the expression of EIF2AK4 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr15:39,934,115...40,035,591
Ensembl chr15:39,934,115...40,035,591
|
|
G |
EIF2B1 |
eukaryotic translation initiation factor 2B subunit alpha |
affects expression |
EXP |
Diclofenac affects the expression of EIF2B1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr12:123,620,406...123,633,686
Ensembl chr12:123,620,406...123,633,766
|
|
G |
EIF2S1 |
eukaryotic translation initiation factor 2 subunit alpha |
affects expression multiple interactions |
EXP |
Diclofenac affects the expression of EIF2S1 mRNA [TNF protein co-treated with Diclofenac] results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:24752500 PMID:27313093 |
|
NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,328...67,386,516
|
|
G |
EIF2S2 |
eukaryotic translation initiation factor 2 subunit beta |
affects expression |
EXP |
Diclofenac affects the expression of EIF2S2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr20:34,088,309...34,112,243
Ensembl chr20:34,088,309...34,112,243
|
|
G |
EIF3A |
eukaryotic translation initiation factor 3 subunit A |
affects expression |
EXP |
Diclofenac affects the expression of EIF3A mRNA |
CTD |
PMID:24752500 |
|
NCBI chr10:119,033,670...119,080,817
Ensembl chr10:119,033,670...119,080,817
|
|
G |
EIF3B |
eukaryotic translation initiation factor 3 subunit B |
affects expression |
EXP |
Diclofenac affects the expression of EIF3B mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 7:2,354,086...2,380,745
Ensembl chr 7:2,354,086...2,380,745
|
|
G |
EIF3C |
eukaryotic translation initiation factor 3 subunit C |
affects expression |
EXP |
Diclofenac affects the expression of EIF3C mRNA |
CTD |
PMID:24752500 |
|
NCBI chr16:28,688,558...28,735,730
Ensembl chr16:28,688,558...28,735,727
|
|
G |
EIF4A1 |
eukaryotic translation initiation factor 4A1 |
affects expression |
EXP |
Diclofenac affects the expression of EIF4A1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr17:7,572,825...7,579,006
Ensembl chr17:7,572,824...7,579,006
|
|
G |
EIF4A2 |
eukaryotic translation initiation factor 4A2 |
affects expression |
EXP |
Diclofenac affects the expression of EIF4A2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 3:186,783,577...186,789,897
Ensembl chr 3:186,783,205...186,789,897
|
|
G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases expression decreases expression affects expression |
ISO EXP |
Diclofenac results in increased expression of EIF4EBP1 mRNA Diclofenac results in decreased expression of EIF4EBP1 mRNA Diclofenac affects the expression of EIF4EBP1 mRNA |
CTD |
PMID:18172885 PMID:24752500 PMID:35537566 |
|
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
|
|
G |
EIF4G1 |
eukaryotic translation initiation factor 4 gamma 1 |
affects expression |
EXP |
Diclofenac affects the expression of EIF4G1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 3:184,314,606...184,335,358
Ensembl chr 3:184,314,495...184,335,358
|
|
G |
EIF4G3 |
eukaryotic translation initiation factor 4 gamma 3 |
affects expression |
EXP |
Diclofenac affects the expression of EIF4G3 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:20,806,292...21,176,897
Ensembl chr 1:20,806,292...21,177,285
|
|
G |
EIF5 |
eukaryotic translation initiation factor 5 |
affects expression |
EXP |
Diclofenac affects the expression of EIF5 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr14:103,334,237...103,345,025
Ensembl chr14:103,333,544...103,345,025
|
|
G |
ELF2 |
E74 like ETS transcription factor 2 |
affects expression |
EXP |
Diclofenac affects the expression of ELF2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 4:139,057,220...139,177,915
Ensembl chr 4:139,028,112...139,177,218
|
|
G |
ELF3 |
E74 like ETS transcription factor 3 |
affects expression |
EXP |
Diclofenac affects the expression of ELF3 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:202,010,587...202,017,183
Ensembl chr 1:202,007,945...202,017,183
|
|
G |
ELOVL2 |
ELOVL fatty acid elongase 2 |
affects expression |
EXP |
Diclofenac affects the expression of ELOVL2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 6:10,980,759...11,044,305
Ensembl chr 6:10,980,759...11,044,305
|
|
G |
ELOVL6 |
ELOVL fatty acid elongase 6 |
increases expression |
ISO |
Diclofenac results in increased expression of ELOVL6 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 4:110,045,846...110,199,202
Ensembl chr 4:110,045,846...110,199,199
|
|
G |
EME2 |
essential meiotic structure-specific endonuclease subunit 2 |
increases expression |
ISO |
Diclofenac results in increased expression of EME2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr16:1,772,810...1,781,702
Ensembl chr16:1,772,810...1,781,708
|
|
G |
ENDOG |
endonuclease G |
affects expression |
EXP |
Diclofenac affects the expression of ENDOG mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 9:128,818,500...128,822,676
Ensembl chr 9:128,818,500...128,822,676
|
|
G |
ENO1 |
enolase 1 |
increases expression |
ISO |
Diclofenac results in increased expression of ENO1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
|
|
G |
ENPP1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
affects expression |
EXP |
Diclofenac affects the expression of ENPP1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 6:131,808,020...131,895,155
Ensembl chr 6:131,808,016...131,895,155
|
|
G |
ENPP2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
increases expression |
ISO |
Diclofenac results in increased expression of ENPP2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 8:119,557,086...119,673,390
Ensembl chr 8:119,557,086...119,673,453
|
|
G |
ENTPD4 |
ectonucleoside triphosphate diphosphohydrolase 4 |
affects expression |
EXP |
Diclofenac affects the expression of ENTPD4 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 8:23,429,162...23,457,647
Ensembl chr 8:23,385,783...23,457,695
|
|
G |
ENTPD5 |
ectonucleoside triphosphate diphosphohydrolase 5 (inactive) |
affects expression |
EXP |
Diclofenac affects the expression of ENTPD5 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr14:73,955,329...74,019,288
Ensembl chr14:73,958,010...74,019,399
|
|
G |
ENTPD7 |
ectonucleoside triphosphate diphosphohydrolase 7 |
affects expression |
EXP |
Diclofenac affects the expression of ENTPD7 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr10:99,659,509...99,711,241
Ensembl chr10:99,659,509...99,711,241
|
|
G |
EPAS1 |
endothelial PAS domain protein 1 |
decreases expression |
EXP |
Diclofenac results in decreased expression of EPAS1 protein |
CTD |
PMID:12912967 |
|
NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697
|
|
G |
EPC2 |
enhancer of polycomb homolog 2 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of EPC2 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 2:148,644,751...148,787,569
Ensembl chr 2:148,644,440...148,788,495
|
|
G |
EPHX1 |
epoxide hydrolase 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of EPHX1 mRNA |
CTD |
PMID:17202759 |
|
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
|
|
G |
EPN2 |
epsin 2 |
affects expression |
EXP |
Diclofenac affects the expression of EPN2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr17:19,237,366...19,336,715
Ensembl chr17:19,215,615...19,336,715
|
|
G |
EPN3 |
epsin 3 |
affects expression |
EXP |
Diclofenac affects the expression of EPN3 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr17:50,532,735...50,543,750
Ensembl chr17:50,532,682...50,543,750
|
|
G |
EPO |
erythropoietin |
affects expression |
EXP |
Diclofenac affects the expression of EPO mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
|
|
G |
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of ERBB4 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841
|
|
G |
EREG |
epiregulin |
increases expression |
EXP |
Diclofenac results in increased expression of EREG mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749
|
|
G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
affects expression |
EXP |
Diclofenac affects the expression of ERN1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
|
|
G |
ERO1A |
endoplasmic reticulum oxidoreductase 1 alpha |
increases expression |
ISO |
Diclofenac results in increased expression of ERO1A mRNA |
CTD |
PMID:26934552 |
|
NCBI chr14:52,639,915...52,695,558
Ensembl chr14:52,639,915...52,695,900
|
|
G |
ESR1 |
estrogen receptor 1 |
affects activity |
EXP |
Diclofenac affects the activity of ESR1 protein |
CTD |
PMID:29777833 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
ETNPPL |
ethanolamine-phosphate phospho-lyase |
decreases expression |
ISO |
Diclofenac results in decreased expression of ETNPPL mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 4:108,742,053...108,763,053
Ensembl chr 4:108,742,048...108,763,054
|
|
G |
EVI5 |
ecotropic viral integration site 5 |
decreases expression |
ISO |
Diclofenac results in decreased expression of EVI5 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 1:92,508,696...92,792,410
Ensembl chr 1:92,508,696...92,792,404
|
|
G |
EXTL1 |
exostosin like glycosyltransferase 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of EXTL1 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 1:26,021,775...26,036,464
Ensembl chr 1:26,019,884...26,036,464
|
|
G |
EYA4 |
EYA transcriptional coactivator and phosphatase 4 |
decreases expression |
ISO |
Diclofenac results in decreased expression of EYA4 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 6:133,240,593...133,532,128
Ensembl chr 6:133,240,514...133,532,128
|
|
G |
F13A1 |
coagulation factor XIII A chain |
increases expression |
ISO |
Diclofenac results in increased expression of F13A1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 6:6,144,084...6,320,662
Ensembl chr 6:6,144,084...6,321,013
|
|
G |
FAAP24 |
FA core complex associated protein 24 |
increases expression |
ISO |
Diclofenac results in increased expression of FAAP24 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr19:32,972,242...32,978,229
Ensembl chr19:32,972,209...32,978,229
|
|
G |
FABP1 |
fatty acid binding protein 1 |
decreases expression increases expression |
EXP ISO |
Diclofenac results in decreased expression of FABP1 mRNA Diclofenac results in increased expression of FABP1 protein |
CTD |
PMID:19022234 PMID:23506792 |
|
NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
|
|
G |
FABP2 |
fatty acid binding protein 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of FABP2 mRNA |
CTD |
PMID:19022234 PMID:26934552 |
|
NCBI chr 4:119,317,250...119,322,138
Ensembl chr 4:119,317,250...119,322,138
|
|
G |
FABP3 |
fatty acid binding protein 3 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of FABP3 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 1:31,359,588...31,373,076
Ensembl chr 1:31,365,253...31,376,850
|
|
G |
FABP4 |
fatty acid binding protein 4 |
decreases expression |
ISO |
Diclofenac results in decreased expression of FABP4 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
|
|
G |
FABP5 |
fatty acid binding protein 5 |
increases expression |
ISO |
Diclofenac results in increased expression of FABP5 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 8:81,280,536...81,284,775
Ensembl chr 8:81,280,536...81,284,777
|
|
G |
FADS1 |
fatty acid desaturase 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of FADS1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr11:61,799,627...61,817,003
Ensembl chr11:61,799,627...61,829,318
|
|
G |
FAM209B |
family with sequence similarity 209 member B |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of FAM209 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr20:56,533,246...56,536,520
Ensembl chr20:56,533,246...56,536,520
|
|
G |
FANCB |
FA complementation group B |
affects expression |
EXP |
Diclofenac affects the expression of FANCB mRNA |
CTD |
PMID:24752500 |
|
NCBI chr X:14,689,524...14,873,069
Ensembl chr X:14,690,388...14,873,255
|
|
G |
FANCC |
FA complementation group C |
affects expression |
EXP |
Diclofenac affects the expression of FANCC mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 9:95,099,054...95,317,709
Ensembl chr 9:95,099,054...95,426,796
|
|
G |
FANCE |
FA complementation group E |
increases expression |
ISO |
Diclofenac results in increased expression of FANCE mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 6:35,452,338...35,467,102
Ensembl chr 6:35,452,338...35,467,104
|
|
G |
FANCF |
FA complementation group F |
affects expression |
EXP |
Diclofenac affects the expression of FANCF mRNA |
CTD |
PMID:24752500 |
|
NCBI chr11:22,622,533...22,625,823
Ensembl chr11:22,622,533...22,625,823
|
|
G |
FANCG |
FA complementation group G |
affects expression |
EXP |
Diclofenac affects the expression of FANCG mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 9:35,073,839...35,079,942
Ensembl chr 9:35,073,835...35,080,004
|
|
G |
FANCL |
FA complementation group L |
affects expression |
EXP |
Diclofenac affects the expression of FANCL mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:58,159,243...58,241,380
Ensembl chr 2:58,159,243...58,241,410
|
|
G |
FANCM |
FA complementation group M |
affects expression |
EXP |
Diclofenac affects the expression of FANCM mRNA |
CTD |
PMID:24752500 |
|
NCBI chr14:45,135,930...45,200,890
Ensembl chr14:45,135,930...45,200,890
|
|
G |
FAS |
Fas cell surface death receptor |
affects expression increases expression |
EXP ISO |
Diclofenac affects the expression of FAS mRNA Diclofenac results in increased expression of FAS mRNA |
CTD |
PMID:24752500 PMID:26934552 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
increases expression |
ISO |
Diclofenac results in increased expression of FASL mRNA |
CTD |
PMID:22285467 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FASN |
fatty acid synthase |
decreases expression |
ISO |
Diclofenac results in decreased expression of FASN mRNA |
CTD |
PMID:19022234 |
|
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
|
|
G |
FASTK |
Fas activated serine/threonine kinase |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of FASTK mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 7:151,076,624...151,080,809
Ensembl chr 7:151,076,624...151,080,866
|
|
G |
FASTKD2 |
FAST kinase domains 2 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of FASTKD2 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 2:206,765,606...206,796,189
Ensembl chr 2:206,765,357...206,796,189
|
|
G |
FBXO33 |
F-box protein 33 |
increases expression |
ISO |
Diclofenac results in increased expression of FBXO33 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr14:39,397,684...39,432,433
Ensembl chr14:39,397,684...39,432,466
|
|
G |
FBXO5 |
F-box protein 5 |
decreases expression |
ISO |
Diclofenac results in decreased expression of FBXO5 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 6:152,970,535...152,983,579
Ensembl chr 6:152,970,519...152,983,579
|
|
G |
FCER1G |
Fc epsilon receptor Ig |
increases expression |
ISO |
Diclofenac results in increased expression of FCER1G mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:161,215,295...161,219,245
Ensembl chr 1:161,215,234...161,220,699
|
|
G |
FCGR2B |
Fc gamma receptor IIb |
decreases expression |
ISO |
Diclofenac results in decreased expression of FCGR2B mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 1:161,647,243...161,678,654
Ensembl chr 1:161,663,143...161,678,654
|
|
G |
FEN1 |
flap structure-specific endonuclease 1 |
increases expression |
ISO |
Diclofenac results in increased expression of FEN1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr11:61,792,911...61,797,238
Ensembl chr11:61,792,911...61,797,238
|
|
G |
FER |
FER tyrosine kinase |
affects expression |
EXP |
Diclofenac affects the expression of FER mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 5:108,747,897...109,196,841
Ensembl chr 5:108,747,841...109,196,841
|
|
G |
FERMT1 |
FERM domain containing kindlin 1 |
increases expression |
ISO |
Diclofenac results in increased expression of FERMT1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr20:6,074,845...6,123,030
Ensembl chr20:6,074,845...6,123,214
|
|
G |
FGB |
fibrinogen beta chain |
multiple interactions increases expression |
ISO |
[Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of FGB protein Diclofenac results in increased expression of FGB mRNA |
CTD |
PMID:25772430 PMID:26934552 |
|
NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
|
|
G |
FGF1 |
fibroblast growth factor 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of FGF1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,178...142,698,070
|
|
G |
FGF3 |
fibroblast growth factor 3 |
increases expression |
ISO |
Diclofenac results in increased expression of FGF3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr11:69,809,968...69,819,416
Ensembl chr11:69,809,968...69,819,416
|
|
G |
FGFR1 |
fibroblast growth factor receptor 1 |
affects expression |
EXP |
Diclofenac affects the expression of FGFR1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834
|
|
G |
FGFR1OP2 |
FGFR1 oncogene partner 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of FGFR1OP2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:26,938,470...26,966,648
Ensembl chr12:26,938,470...26,966,650
|
|
G |
FGG |
fibrinogen gamma chain |
multiple interactions decreases expression |
ISO |
[Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of FGG protein; Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of FGG protein]; lipopolysaccharide, E coli O55-B5 promotes the reaction [Diclofenac results in decreased expression of FGG protein] |
CTD |
PMID:25772430 |
|
NCBI chr 4:154,604,136...154,612,656
Ensembl chr 4:154,604,134...154,612,967
|
|
G |
FGL1 |
fibrinogen like 1 |
increases expression |
ISO |
Diclofenac results in increased expression of FGL1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 8:17,864,389...17,895,538
Ensembl chr 8:17,864,380...17,910,365
|
|
G |
FMOD |
fibromodulin |
decreases expression |
ISO |
Diclofenac results in decreased expression of FMOD mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:203,340,628...203,351,122
Ensembl chr 1:203,340,628...203,351,758
|
|
G |
FN1 |
fibronectin 1 |
increases expression |
ISO |
Diclofenac results in increased expression of FN1 mRNA; Diclofenac results in increased expression of FN1 protein |
CTD |
PMID:26934552 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FNBP1 |
formin binding protein 1 |
affects expression |
EXP |
Diclofenac affects the expression of FNBP1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 9:129,887,187...130,053,879
Ensembl chr 9:129,887,187...130,043,189
|
|
G |
FNDC3B |
fibronectin type III domain containing 3B |
increases expression |
ISO |
Diclofenac results in increased expression of FNDC3B mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:172,039,578...172,401,669
Ensembl chr 3:172,039,578...172,401,669
|
|
G |
FNIP1 |
folliculin interacting protein 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of FNIP1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:131,641,714...131,797,017
Ensembl chr 5:131,641,714...131,797,017
|
|
G |
FNIP2 |
folliculin interacting protein 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of FNIP2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 4:158,769,026...158,908,050
Ensembl chr 4:158,769,026...158,908,050
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions affects expression |
EXP ISO |
Diclofenac results in increased expression of FOS mRNA [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of FOS mRNA Diclofenac affects the expression of FOS mRNA |
CTD |
PMID:12730611 PMID:24752500 PMID:37844793 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
FOSL2 |
FOS like 2, AP-1 transcription factor subunit |
increases expression |
ISO |
Diclofenac results in increased expression of FOSL2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 2:28,392,858...28,417,317
Ensembl chr 2:28,392,448...28,417,317
|
|
G |
FOXA1 |
forkhead box A1 |
affects expression |
EXP |
Diclofenac affects the expression of FOXA1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr14:37,589,552...37,595,249
Ensembl chr14:37,589,552...37,596,059
|
|
G |
FOXA3 |
forkhead box A3 |
increases expression |
ISO |
Diclofenac results in increased expression of FOXA3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr19:45,864,326...45,873,797
Ensembl chr19:45,863,989...45,873,797
|
|
G |
FOXO1 |
forkhead box O1 |
affects expression |
EXP |
Diclofenac affects the expression of FOXO1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641
|
|
G |
FOXO3 |
forkhead box O3 |
affects expression decreases expression |
EXP ISO |
Diclofenac affects the expression of FOXO3 mRNA Diclofenac results in decreased expression of FOXO3 mRNA |
CTD |
PMID:24752500 PMID:26934552 |
|
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
|
|
G |
FPR2 |
formyl peptide receptor 2 |
increases expression |
ISO |
Diclofenac results in increased expression of FPR2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr19:51,761,180...51,770,531
Ensembl chr19:51,752,026...51,770,531
|
|
G |
FRAT2 |
FRAT regulator of WNT signaling pathway 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of FRAT2 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr10:97,332,497...97,334,729
Ensembl chr10:97,332,497...97,334,729
|
|
G |
FRS2 |
fibroblast growth factor receptor substrate 2 |
affects expression |
EXP |
Diclofenac affects the expression of FRS2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr12:69,470,388...69,579,793
Ensembl chr12:69,470,349...69,579,793
|
|
G |
FTCD |
formimidoyltransferase cyclodeaminase |
affects expression |
EXP |
Diclofenac affects the expression of FTCD mRNA |
CTD |
PMID:24752500 |
|
NCBI chr21:46,136,262...46,155,579
Ensembl chr21:46,136,160...46,155,579
|
|
G |
FYB1 |
FYN binding protein 1 |
increases expression |
ISO |
Diclofenac results in increased expression of FYB1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:39,105,252...39,274,528
Ensembl chr 5:39,105,252...39,274,528
|
|
G |
FZD3 |
frizzled class receptor 3 |
affects expression |
EXP |
Diclofenac affects the expression of FZD3 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 8:28,494,212...28,574,258
Ensembl chr 8:28,494,205...28,574,267
|
|
G |
FZD4 |
frizzled class receptor 4 |
affects expression |
EXP |
Diclofenac affects the expression of FZD4 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr11:86,945,679...86,955,395
Ensembl chr11:86,945,679...86,955,395
|
|
G |
FZD5 |
frizzled class receptor 5 |
affects expression |
EXP |
Diclofenac affects the expression of FZD5 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:207,762,598...207,769,906
Ensembl chr 2:207,762,598...207,769,906
|
|
G |
FZD6 |
frizzled class receptor 6 |
affects expression |
EXP |
Diclofenac affects the expression of FZD6 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 8:103,298,494...103,332,866
Ensembl chr 8:103,298,433...103,332,866
|
|
G |
FZD7 |
frizzled class receptor 7 |
affects expression |
EXP |
Diclofenac affects the expression of FZD7 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:202,033,855...202,038,441
Ensembl chr 2:202,033,855...202,038,441
|
|
G |
GAB1 |
GRB2 associated binding protein 1 |
affects expression |
EXP |
Diclofenac affects the expression of GAB1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 4:143,336,876...143,474,565
Ensembl chr 4:143,336,876...143,474,565
|
|
G |
GAB2 |
GRB2 associated binding protein 2 |
affects expression |
EXP |
Diclofenac affects the expression of GAB2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr11:78,215,293...78,417,820
Ensembl chr11:78,215,293...78,418,348
|
|
G |
GABRA5 |
gamma-aminobutyric acid type A receptor subunit alpha5 |
decreases expression |
ISO |
Diclofenac results in decreased expression of GABRA5 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr15:26,866,719...26,949,208
Ensembl chr15:26,866,911...26,949,208
|
|
G |
GADD45A |
growth arrest and DNA damage inducible alpha |
increases expression decreases expression affects expression |
EXP ISO |
Diclofenac results in increased expression of GADD45A mRNA Diclofenac results in decreased expression of GADD45A mRNA Diclofenac affects the expression of GADD45A mRNA |
CTD |
PMID:18172885 PMID:19022234 PMID:24752500 PMID:26934552 PMID:35537566 |
|
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
|
|
G |
GADD45G |
growth arrest and DNA damage inducible gamma |
increases expression |
ISO |
Diclofenac results in increased expression of GADD45G mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555
|
|
G |
GALNT3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
increases expression |
ISO |
Diclofenac results in increased expression of GALNT3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:165,747,588...165,794,692
Ensembl chr 2:165,747,588...165,846,201
|
|
G |
GARS1 |
glycyl-tRNA synthetase 1 |
affects expression decreases expression |
EXP ISO |
Diclofenac affects the expression of GARS1 mRNA Diclofenac results in decreased expression of GARS1 mRNA |
CTD |
PMID:24752500 PMID:35537566 |
|
NCBI chr 7:30,594,735...30,634,033
Ensembl chr 7:30,580,533...30,634,033
|
|
G |
GART |
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase |
affects expression |
EXP |
Diclofenac affects the expression of GART mRNA |
CTD |
PMID:24752500 |
|
NCBI chr21:33,503,931...33,542,893
Ensembl chr21:33,503,931...33,543,491
|
|
G |
GAS1 |
growth arrest specific 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of GAS1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 9:86,944,362...86,947,506
Ensembl chr 9:86,944,362...86,947,506
|
|
G |
GATA4 |
GATA binding protein 4 |
affects expression |
EXP |
Diclofenac affects the expression of GATA4 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 8:11,676,935...11,760,002
Ensembl chr 8:11,676,959...11,760,002
|
|
G |
GATA6 |
GATA binding protein 6 |
increases expression |
ISO |
Diclofenac results in increased expression of GATA6 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr18:22,169,589...22,202,528
Ensembl chr18:22,169,589...22,202,528
|
|
G |
GBP1 |
guanylate binding protein 1 |
decreases expression |
EXP |
Diclofenac results in decreased expression of GBP1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 1:89,052,319...89,065,208
Ensembl chr 1:89,051,882...89,065,360
|
|
G |
GBP4 |
guanylate binding protein 4 |
increases expression |
ISO |
Diclofenac results in increased expression of GBP3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:89,181,144...89,198,942
Ensembl chr 1:89,181,144...89,198,942
|
|
G |
GC |
GC vitamin D binding protein |
multiple interactions |
ISO |
[Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of GC protein |
CTD |
PMID:25772430 |
|
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
|
|
G |
GCK |
glucokinase |
affects expression |
ISO |
Diclofenac affects the expression of GCK mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 7:44,143,213...44,189,439
Ensembl chr 7:44,143,213...44,198,170
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
decreases expression affects expression affects response to substance |
ISO EXP |
Diclofenac results in decreased expression of GCLC mRNA Diclofenac affects the expression of GCLC mRNA GCLC protein affects the susceptibility to Diclofenac |
CTD |
PMID:17202759 PMID:19481141 PMID:24752500 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
affects expression |
EXP |
Diclofenac affects the expression of GCLM mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GDF15 |
growth differentiation factor 15 |
increases expression |
ISO EXP |
Diclofenac results in increased expression of GDF15 mRNA Diclofenac results in increased expression of GDF15 protein |
CTD |
PMID:15555568 PMID:18076062 |
|
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
|
|
G |
GDF6 |
growth differentiation factor 6 |
increases expression |
ISO |
Diclofenac results in increased expression of GDF6 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:96,142,333...96,160,806
Ensembl chr 8:96,142,333...96,160,806
|
|
G |
GDF9 |
growth differentiation factor 9 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of GDF9 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 5:132,861,185...132,866,651
Ensembl chr 5:132,861,181...132,866,884
|
|
G |
GFPT1 |
glutamine--fructose-6-phosphate transaminase 1 |
increases expression |
ISO |
Diclofenac results in increased expression of GFPT1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 2:69,319,780...69,387,227
Ensembl chr 2:69,319,780...69,387,250
|
|
G |
GGT1 |
gamma-glutamyltransferase 1 |
multiple interactions |
ISO |
[lipopolysaccharide, E coli O55-B5 co-treated with Diclofenac] results in increased activity of GGT1 protein |
CTD |
PMID:23939143 |
|
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
|
|
G |
GHR |
growth hormone receptor |
affects expression |
ISO |
Diclofenac affects the expression of GHR protein |
CTD |
PMID:26934552 |
|
NCBI chr 5:42,423,439...42,721,878
Ensembl chr 5:42,423,439...42,721,878
|
|
G |
GIT2 |
GIT ArfGAP 2 |
affects expression |
EXP |
Diclofenac affects the expression of GIT2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr12:109,929,804...110,000,164
Ensembl chr12:109,929,804...109,996,389
|
|
G |
GJA1 |
gap junction protein alpha 1 |
increases expression |
ISO |
Diclofenac results in increased expression of GJA1 mRNA |
CTD |
PMID:26934552 PMID:35537566 |
|
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
|
|
G |
GJA3 |
gap junction protein alpha 3 |
increases expression |
ISO |
Diclofenac results in increased expression of GJA3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr13:20,138,255...20,161,565
Ensembl chr13:20,138,255...20,161,052
|
|
G |
GLDC |
glycine decarboxylase |
affects expression |
EXP |
Diclofenac affects the expression of GLDC mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 9:6,532,467...6,645,729
Ensembl chr 9:6,532,467...6,645,729
|
|
G |
GLYCTK |
glycerate kinase |
affects expression |
EXP |
Diclofenac affects the expression of GLYCTK mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 3:52,287,828...52,295,257
Ensembl chr 3:52,287,089...52,295,257
|
|
G |
GNA13 |
G protein subunit alpha 13 |
affects expression |
EXP |
Diclofenac affects the expression of GNA13 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr17:65,009,289...65,056,740
Ensembl chr17:65,009,289...65,056,740
|
|
G |
GNAQ |
G protein subunit alpha q |
affects expression |
EXP |
Diclofenac affects the expression of GNAQ mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 9:77,716,097...78,031,811
Ensembl chr 9:77,716,097...78,031,811
|
|
G |
GNAS |
GNAS complex locus |
affects expression |
EXP |
Diclofenac affects the expression of GNAS mRNA |
CTD |
PMID:24752500 |
|
NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192
|
|
G |
GNAT1 |
G protein subunit alpha transducin 1 |
increases expression |
ISO |
Diclofenac results in increased expression of GNAT1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:50,191,610...50,197,696
Ensembl chr 3:50,191,610...50,197,696
|
|
G |
GNB5 |
G protein subunit beta 5 |
affects expression |
EXP |
Diclofenac affects the expression of GNB5 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr15:52,115,100...52,191,392
Ensembl chr15:52,115,100...52,191,392
|
|
G |
GNG4 |
G protein subunit gamma 4 |
affects expression |
EXP |
Diclofenac affects the expression of GNG4 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 1:235,547,685...235,650,608
Ensembl chr 1:235,547,685...235,650,754
|
|
G |
GOT1 |
glutamic-oxaloacetic transaminase 1 |
affects expression increases secretion |
EXP |
Diclofenac affects the expression of GOT1 mRNA Diclofenac results in increased secretion of GOT1 protein |
CTD |
PMID:24752500 PMID:36442613 |
|
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
|
|
G |
GPD1 |
glycerol-3-phosphate dehydrogenase 1 |
multiple interactions |
ISO |
Diclofenac inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of GPD1 protein] |
CTD |
PMID:25772430 |
|
NCBI chr12:50,104,008...50,111,313
Ensembl chr12:50,103,982...50,111,313
|
|
G |
GPLD1 |
glycosylphosphatidylinositol specific phospholipase D1 |
affects expression |
EXP |
Diclofenac affects the expression of GPLD1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 6:24,423,969...24,495,287
Ensembl chr 6:24,424,565...24,495,205
|
|
G |
GPR176 |
G protein-coupled receptor 176 |
decreases expression |
ISO |
Diclofenac results in decreased expression of GPR176 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr15:39,799,008...39,920,266
Ensembl chr15:39,799,008...39,920,936
|
|
G |
GPR20 |
G protein-coupled receptor 20 |
decreases expression |
ISO |
Diclofenac results in decreased expression of GPR20 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:141,356,470...141,367,286
Ensembl chr 8:141,356,470...141,367,286
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions increases secretion increases expression increases activity |
ISO EXP |
[lipopolysaccharide, E coli O55-B5 co-treated with Diclofenac] results in increased activity of GPT protein; Diclofenac promotes the reaction [endotoxin, Escherichia coli results in increased activity of GPT protein]; Heparin inhibits the reaction [Diclofenac promotes the reaction [endotoxin, Escherichia coli results in increased activity of GPT protein]] Diclofenac results in increased secretion of GPT protein Diclofenac results in increased expression of GPT protein Diclofenac results in increased activity of GPT protein eritoran inhibits the reaction [Diclofenac results in increased expression of GPT protein] |
CTD |
PMID:23939143 PMID:24747151 PMID:26934552 PMID:27671914 PMID:30925002 PMID:31813902 PMID:36442613 More...
|
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GPT2 |
glutamic--pyruvic transaminase 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of GPT2 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr16:46,884,362...46,931,289
Ensembl chr16:46,884,362...46,931,289
|
|
G |
GPX1 |
glutathione peroxidase 1 |
increases expression |
ISO EXP |
Diclofenac results in increased expression of GPX1 mRNA; Diclofenac results in increased expression of GPX1 protein |
CTD |
PMID:25772430 PMID:29027214 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GPX2 |
glutathione peroxidase 2 |
affects expression |
EXP |
Diclofenac affects the expression of GPX2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
|
|
G |
GRB10 |
growth factor receptor bound protein 10 |
affects expression |
EXP |
Diclofenac affects the expression of GRB10 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 7:50,590,068...50,793,453
Ensembl chr 7:50,590,063...50,793,462
|
|
G |
GRID2 |
glutamate ionotropic receptor delta type subunit 2 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of GRID2 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 4:92,303,966...93,810,456
Ensembl chr 4:92,303,966...93,810,157
|
|
G |
GRM7 |
glutamate metabotropic receptor 7 |
increases expression |
ISO |
Diclofenac results in increased expression of GRM7 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:6,861,115...7,741,533
Ensembl chr 3:6,770,001...7,741,533
|
|
G |
GSDMD |
gasdermin D |
increases cleavage multiple interactions |
ISO |
Diclofenac results in increased cleavage of GSDMD protein diacerein inhibits the reaction [Diclofenac results in increased cleavage of GSDMD protein] |
CTD |
PMID:38582345 |
|
NCBI chr 8:143,553,387...143,563,062
Ensembl chr 8:143,553,207...143,563,062
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
affects expression |
EXP |
Diclofenac affects the expression of GSK3B mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
GSN |
gelsolin |
decreases expression |
ISO |
Diclofenac results in decreased expression of GSN mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
|
|
G |
GSTA1 |
glutathione S-transferase alpha 1 |
decreases activity |
EXP |
Diclofenac results in decreased activity of GSTA1 protein |
CTD |
PMID:27183920 |
|
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
|
|
G |
GSTA3 |
glutathione S-transferase alpha 3 |
decreases activity |
EXP |
Diclofenac results in decreased activity of GSTA3 protein |
CTD |
PMID:27183920 |
|
NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,698
|
|
G |
GSTA4 |
glutathione S-transferase alpha 4 |
decreases activity |
EXP |
Diclofenac results in decreased activity of GSTA4 protein |
CTD |
PMID:27183920 |
|
NCBI chr 6:52,977,953...52,995,284
Ensembl chr 6:52,977,948...52,995,304
|
|
G |
GSTA5 |
glutathione S-transferase alpha 5 |
increases expression multiple interactions |
ISO |
Diclofenac results in increased expression of GSTA5 protein [Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of GSTA5 protein |
CTD |
PMID:25772430 |
|
NCBI chr 6:52,831,692...52,846,245
Ensembl chr 6:52,831,655...52,840,843
|
|
G |
GSTM1 |
glutathione S-transferase mu 1 |
decreases activity decreases expression |
EXP ISO |
Diclofenac results in decreased activity of GSTM1 protein Diclofenac results in decreased expression of GSTM1 mRNA |
CTD |
PMID:26934552 PMID:27183920 |
|
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
|
|
G |
GSTM2 |
glutathione S-transferase mu 2 |
decreases activity |
EXP |
Diclofenac results in decreased activity of GSTM2 protein |
CTD |
PMID:27183920 |
|
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
|
|
G |
GSTM3 |
glutathione S-transferase mu 3 |
increases expression |
ISO |
Diclofenac results in increased expression of GSTM3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
|
|
G |
GSTM4 |
glutathione S-transferase mu 4 |
affects activity |
EXP |
Diclofenac affects the activity of GSTM4 protein |
CTD |
PMID:27183920 |
|
NCBI chr 1:109,656,099...109,667,727
Ensembl chr 1:109,656,099...109,665,496
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
multiple interactions affects activity affects metabolic processing |
EXP |
[[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac; [[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac; [[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 5-hydroxydiclofenac; [CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac; [CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased metabolism of Diclofenac; [CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac; [CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of Diclofenac; [CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac Diclofenac affects the activity of GSTP1 protein GSTP1 protein affects the metabolism of Diclofenac metabolite; GSTP1 protein polymorphism affects the metabolism of Diclofenac metabolite |
CTD |
PMID:24185126 PMID:24246759 PMID:27183920 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
GSTT1 |
glutathione S-transferase theta 1 |
affects expression affects activity |
EXP |
Diclofenac affects the expression of GSTT1 mRNA Diclofenac affects the activity of GSTT1 protein |
CTD |
PMID:24752500 PMID:27183920 |
|
|
|
G |
GSTT3P |
glutathione S-transferase theta 3, pseudogene |
decreases expression |
ISO |
Diclofenac results in decreased expression of GSTT3 mRNA |
CTD |
PMID:26934552 |
|
|
|
G |
GTF2H4 |
general transcription factor IIH subunit 4 |
affects expression |
EXP |
Diclofenac affects the expression of GTF2H4 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 6:30,908,207...30,914,106
Ensembl chr 6:30,908,207...30,914,106
|
|
G |
GTF2H5 |
general transcription factor IIH subunit 5 |
affects expression |
EXP |
Diclofenac affects the expression of GTF2H5 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 6:158,168,350...158,199,344
Ensembl chr 6:158,168,350...158,199,344
|
|
G |
GTPBP2 |
GTP binding protein 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of GTPBP2 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 6:43,620,494...43,631,333
Ensembl chr 6:43,605,316...43,629,264
|
|
G |
H2AX |
H2A.X variant histone |
increases expression |
EXP |
Diclofenac results in increased expression of H2AX protein |
CTD |
PMID:32087850 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
G |
H2BC4 |
H2B clustered histone 4 |
decreases expression |
ISO |
Diclofenac results in decreased expression of H2BC21 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 6:26,113,170...26,123,926
Ensembl chr 6:26,086,317...26,123,926
|
|
G |
HAMP |
hepcidin antimicrobial peptide |
affects expression decreases secretion |
ISO |
Diclofenac affects the expression of HAMP mRNA Diclofenac results in decreased secretion of HAMP protein |
CTD |
PMID:24038040 PMID:26934552 |
|
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
|
|
G |
HAT1 |
histone acetyltransferase 1 |
affects expression |
EXP |
Diclofenac affects the expression of HAT1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:171,922,461...171,983,686
Ensembl chr 2:171,922,448...171,983,686
|
|
G |
HAVCR1 |
hepatitis A virus cellular receptor 1 |
increases expression increases secretion multiple interactions |
EXP ISO |
Diclofenac results in increased expression of HAVCR1 mRNA Diclofenac results in increased secretion of HAVCR1 protein diacerein inhibits the reaction [Diclofenac results in increased secretion of HAVCR1 protein] |
CTD |
PMID:23506792 PMID:38582345 |
|
NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
|
|
G |
HBA1 |
hemoglobin subunit alpha 1 |
increases expression |
ISO |
Diclofenac results in increased expression of HBA-A2 protein |
CTD |
PMID:14565772 |
|
NCBI chr16:176,680...177,522
Ensembl chr16:176,680...177,522
|
|
G |
HBB |
hemoglobin subunit beta |
increases expression |
ISO |
Diclofenac results in increased expression of HBB protein |
CTD |
PMID:14565772 |
|
NCBI chr11:5,225,464...5,227,071
Ensembl chr11:5,225,464...5,229,395
|
|
G |
HBEGF |
heparin binding EGF like growth factor |
affects expression decreases expression increases expression |
EXP ISO |
Diclofenac affects the expression of HBEGF mRNA Diclofenac results in decreased expression of HBEGF mRNA Diclofenac results in increased expression of HBEGF mRNA |
CTD |
PMID:24752500 PMID:26934552 PMID:35537566 |
|
NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
|
|
G |
HCK |
HCK proto-oncogene, Src family tyrosine kinase |
increases expression |
ISO |
Diclofenac results in increased expression of HCK mRNA |
CTD |
PMID:26934552 |
|
NCBI chr20:32,052,242...32,101,856
Ensembl chr20:32,052,197...32,101,856
|
|
G |
HERC5 |
HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
decreases expression |
EXP |
Diclofenac results in decreased expression of HERC5 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 4:88,457,119...88,506,163
Ensembl chr 4:88,457,119...88,506,163
|
|
G |
HERC6 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
decreases expression increases expression |
EXP ISO |
Diclofenac results in decreased expression of HERC6 mRNA Diclofenac results in increased expression of HERC6 mRNA |
CTD |
PMID:19192274 PMID:26934552 |
|
NCBI chr 4:88,378,852...88,443,097
Ensembl chr 4:88,378,739...88,443,097
|
|
G |
HERPUD1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
affects expression decreases expression |
EXP ISO |
Diclofenac affects the expression of HERPUD1 mRNA Diclofenac results in decreased expression of HERPUD1 mRNA |
CTD |
PMID:24752500 PMID:26934552 PMID:35537566 |
|
NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864
|
|
G |
HES6 |
hes family bHLH transcription factor 6 |
decreases expression |
ISO |
Diclofenac results in decreased expression of HES6 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 2:238,238,267...238,240,038
Ensembl chr 2:238,238,267...238,240,662
|
|
G |
HHEX |
hematopoietically expressed homeobox |
decreases expression |
ISO |
Diclofenac results in decreased expression of HHEX mRNA |
CTD |
PMID:26934552 |
|
NCBI chr10:92,689,955...92,695,647
Ensembl chr10:92,689,955...92,695,647
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
decreases expression |
EXP |
Diclofenac results in decreased expression of HIF1A protein |
CTD |
PMID:12912967 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HK1 |
hexokinase 1 |
increases expression |
ISO |
Diclofenac results in increased expression of HK1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr10:69,270,000...69,401,882
Ensembl chr10:69,269,984...69,401,884
|
|
G |
HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of RT1-BB mRNA |
CTD |
PMID:17202759 |
|
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
|
|
G |
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
affects expression |
EXP |
Diclofenac affects the expression of HLA-DRB1 mRNA |
CTD |
PMID:25811541 |
|
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
|
|
G |
HMGB1 |
high mobility group box 1 |
multiple interactions increases expression affects expression |
ISO EXP |
Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of HMGB1 protein] Diclofenac results in increased expression of HMGB1 mRNA; Diclofenac results in increased expression of HMGB1 protein Diclofenac affects the expression of HMGB1 mRNA |
CTD |
PMID:23939143 PMID:24747151 PMID:24752500 PMID:26934552 |
|
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
|
|
G |
HMGCS2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of HMGCS2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:119,747,996...119,768,932
Ensembl chr 1:119,748,002...119,768,905
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions decreases expression increases expression affects expression |
EXP ISO |
1-aminobenzotriazole inhibits the reaction [[Diclofenac co-treated with Buthionine Sulfoximine] results in increased expression of HMOX1 mRNA]; Buthionine Sulfoximine promotes the reaction [Diclofenac results in increased expression of HMOX1 mRNA] Diclofenac results in decreased expression of HMOX1 protein Diclofenac results in increased expression of HMOX1 mRNA; Diclofenac results in increased expression of HMOX1 protein Acetylcysteine inhibits the reaction [Diclofenac results in increased expression of HMOX1 protein]; Buthionine Sulfoximine promotes the reaction [Diclofenac results in increased expression of HMOX1 protein]; Diclofenac promotes the reaction [Buthionine Sulfoximine results in increased expression of HMOX1 protein] Acetylcysteine inhibits the reaction [Diclofenac results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Diclofenac results in increased expression of HMOX1 mRNA]; diacerein inhibits the reaction [Diclofenac results in decreased expression of HMOX1 protein]; Diclofenac promotes the reaction [Poly I-C results in increased expression of HMOX1 mRNA]; Ketoconazole inhibits the reaction [Diclofenac results in increased expression of HMOX1 mRNA]; Sulfaphenazole inhibits the reaction [Diclofenac results in increased expression of HMOX1 mRNA]; Tranylcypromine inhibits the reaction [Diclofenac results in increased expression of HMOX1 mRNA] Diclofenac affects the expression of HMOX1 protein |
CTD |
PMID:12763371 PMID:18172885 PMID:18227147 PMID:19022234 PMID:19952508 PMID:23939143 PMID:27313093 PMID:29027214 PMID:38582345 More...
|
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HMX3 |
H6 family homeobox 3 |
decreases expression |
ISO |
Diclofenac results in decreased expression of HMX3 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr10:123,135,970...123,139,423
Ensembl chr10:123,135,970...123,139,423
|
|
G |
HNF1A |
HNF1 homeobox A |
affects expression |
EXP |
Diclofenac affects the expression of HNF1A mRNA |
CTD |
PMID:24752500 |
|
NCBI chr12:120,978,543...121,002,512
Ensembl chr12:120,978,543...121,002,512
|
|
G |
HNF4A |
hepatocyte nuclear factor 4 alpha |
decreases expression |
ISO |
Diclofenac results in decreased expression of HNF4A mRNA |
CTD |
PMID:19022234 |
|
NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,699...44,432,845
|
|
G |
HNRNPD |
heterogeneous nuclear ribonucleoprotein D |
affects expression |
EXP |
Diclofenac affects the expression of HNRNPD mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 4:82,352,498...82,373,991
Ensembl chr 4:82,352,498...82,374,503
|
|
G |
HOATZ |
HOATZ cilia and flagella associated protein |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of HOATZ mRNA |
CTD |
PMID:37844793 |
|
NCBI chr11:111,514,778...111,537,043
Ensembl chr11:111,514,778...111,537,043
|
|
G |
HP |
haptoglobin |
increases expression decreases expression |
ISO |
Diclofenac results in increased expression of HP mRNA Diclofenac results in decreased expression of HP mRNA |
CTD |
PMID:26934552 |
|
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
|
|
G |
HPGD |
15-hydroxyprostaglandin dehydrogenase |
increases activity multiple interactions increases expression |
EXP |
Diclofenac results in increased activity of HPGD protein [Diclofenac co-treated with NAD] binds to HPGD protein Diclofenac results in increased expression of HPGD mRNA |
CTD |
PMID:19501039 PMID:25526675 |
|
NCBI chr 4:174,490,175...174,522,893
Ensembl chr 4:174,490,175...174,523,154
|
|
G |
HRAS |
HRas proto-oncogene, GTPase |
affects expression |
EXP |
Diclofenac affects the expression of HRAS mRNA |
CTD |
PMID:24752500 |
|
NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
|
|
G |
HS3ST3B1 |
heparan sulfate-glucosamine 3-sulfotransferase 3B1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of HS3ST3B1 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr17:14,301,081...14,349,404
Ensembl chr17:14,301,081...14,349,404
|
|
G |
HS6ST2 |
heparan sulfate 6-O-sulfotransferase 2 |
increases expression |
ISO |
Diclofenac results in increased expression of HS6ST2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr X:132,626,015...132,961,370
Ensembl chr X:132,626,015...132,961,395
|
|
G |
HSD3B1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of HSD3B2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
|
|
G |
HSF1 |
heat shock transcription factor 1 |
increases activity |
EXP |
Diclofenac results in increased activity of HSF1 protein |
CTD |
PMID:34170685 |
|
NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,591...144,314,720
|
|
G |
HSP90AA1 |
heat shock protein 90 alpha family class A member 1 |
multiple interactions |
ISO |
Diclofenac inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of HSP90AA1 mRNA] |
CTD |
PMID:23939143 |
|
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
|
|
G |
HSPA1A |
heat shock protein family A (Hsp70) member 1A |
multiple interactions affects expression increases expression |
ISO |
Diclofenac inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of HSPA1A mRNA] [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of HSPA1A mRNA Diclofenac affects the expression of HSPA1A mRNA Diclofenac results in increased expression of HSPA1A mRNA |
CTD |
PMID:19022234 PMID:23939143 PMID:25014874 PMID:26934552 PMID:37844793 |
|
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
|
|
G |
HSPA1B |
heat shock protein family A (Hsp70) member 1B |
increases expression multiple interactions |
ISO |
Diclofenac results in increased expression of HSPA1B mRNA [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of HSPA1B mRNA |
CTD |
PMID:26934552 PMID:37844793 |
|
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
increases expression multiple interactions |
ISO EXP |
Diclofenac results in increased expression of HSPA5 mRNA [Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of HSPA5 protein |
CTD |
PMID:25014874 PMID:25772430 PMID:27313093 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
multiple interactions increases expression |
ISO |
Diclofenac inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of HSPA8 mRNA] Diclofenac results in increased expression of HSPA8 mRNA |
CTD |
PMID:23939143 PMID:26934552 |
|
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
|
|
G |
HSPB1 |
heat shock protein family B (small) member 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of HSPB1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,305,813
|
|
G |
HSPB8 |
heat shock protein family B (small) member 8 |
increases expression |
ISO |
Diclofenac results in increased expression of HSPB8 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:119,178,931...119,194,746
Ensembl chr12:119,171,555...119,224,855
|
|
G |
IARS1 |
isoleucyl-tRNA synthetase 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of IARS1 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 9:92,210,207...92,293,697
Ensembl chr 9:92,210,207...92,293,854
|
|
G |
IBTK |
inhibitor of Bruton tyrosine kinase |
increases expression |
ISO |
Diclofenac results in increased expression of IBTK mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 6:82,169,987...82,247,744
Ensembl chr 6:82,169,986...82,247,754
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
multiple interactions increases expression decreases expression affects expression |
ISO EXP |
Amlodipine inhibits the reaction [Diclofenac results in decreased expression of ICAM1 protein] Diclofenac results in increased expression of ICAM1 mRNA Diclofenac results in decreased expression of ICAM1 mRNA Diclofenac affects the expression of ICAM1 mRNA |
CTD |
PMID:14716214 PMID:18460984 PMID:24752500 PMID:26934552 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
ID2 |
inhibitor of DNA binding 2 |
increases expression |
ISO |
Diclofenac results in increased expression of ID2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
|
|
G |
ID3 |
inhibitor of DNA binding 3 |
increases expression |
ISO |
Diclofenac results in increased expression of ID3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:23,557,926...23,559,501
Ensembl chr 1:23,557,926...23,559,501
|
|
G |
IDH2 |
isocitrate dehydrogenase (NADP(+)) 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of IDH2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
|
|
G |
IER3 |
immediate early response 3 |
increases expression |
ISO |
Diclofenac results in increased expression of IER3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
|
|
G |
IFI27 |
interferon alpha inducible protein 27 |
decreases expression |
EXP |
Diclofenac results in decreased expression of IFI27 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr14:94,105,894...94,116,690
Ensembl chr14:94,104,836...94,116,695
|
|
G |
IFI35 |
interferon induced protein 35 |
decreases expression |
EXP |
Diclofenac results in decreased expression of IFI35 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr17:43,006,784...43,014,456
Ensembl chr17:43,006,740...43,014,456
|
|
G |
IFI44 |
interferon induced protein 44 |
decreases expression |
EXP ISO |
Diclofenac results in decreased expression of IFI44 mRNA |
CTD |
PMID:19192274 PMID:35537566 |
|
NCBI chr 1:78,649,789...78,664,078
Ensembl chr 1:78,649,796...78,664,078
|
|
G |
IFI44L |
interferon induced protein 44 like |
decreases expression |
EXP |
Diclofenac results in decreased expression of IFI44L mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 1:78,620,448...78,646,145
Ensembl chr 1:78,619,902...78,646,145
|
|
G |
IFI6 |
interferon alpha inducible protein 6 |
decreases expression |
EXP |
Diclofenac results in decreased expression of IFI6 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 1:27,666,064...27,672,192
Ensembl chr 1:27,666,064...27,672,212
|
|
G |
IFIH1 |
interferon induced with helicase C domain 1 |
decreases expression |
EXP |
Diclofenac results in decreased expression of IFIH1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684
|
|
G |
IFIT1 |
interferon induced protein with tetratricopeptide repeats 1 |
decreases expression |
EXP |
Diclofenac results in decreased expression of IFIT1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487
|
|
G |
IFIT3 |
interferon induced protein with tetratricopeptide repeats 3 |
decreases expression |
EXP |
Diclofenac results in decreased expression of IFIT3 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr10:89,327,997...89,340,968
Ensembl chr10:89,327,307...89,377,473
|
|
G |
IFITM2 |
interferon induced transmembrane protein 2 |
increases expression |
ISO |
Diclofenac results in increased expression of IFITM2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr11:307,816...309,395
Ensembl chr11:303,655...309,397
|
|
G |
IFITM3 |
interferon induced transmembrane protein 3 |
increases expression |
ISO |
Diclofenac results in increased expression of IFITM3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475
|
|
G |
IFNA13 |
interferon alpha 13 |
increases expression |
ISO |
Diclofenac results in increased expression of IFNA9 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 9:21,367,372...21,368,057
Ensembl chr 9:21,367,372...21,368,057
|
|
G |
IFNG |
interferon gamma |
multiple interactions decreases expression |
ISO EXP |
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Diclofenac promotes the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Diclofenac promotes the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]]; Diclofenac inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNG protein]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in decreased expression of NFKBIA protein]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein]; Diclofenac promotes the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Diclofenac promotes the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNG mRNA]; Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNG protein]; RELA mutant form inhibits the reaction [Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]]; SN50 peptide inhibits the reaction [Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[Diclofenac co-treated with IFNG protein] results in increased phosphorylation of STAT1 protein]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[TNF protein co-treated with IFNG protein] promotes the reaction [Diclofenac results in increased activity of CASP3 protein]]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [IFNG protein promotes the reaction [Diclofenac results in increased activity of CASP3 protein]]; 2-aminoethoxydiphenyl borate inhibits the reaction [[Diclofenac co-treated with IFNG protein] results in increased phosphorylation of STAT1 protein]; 2-aminoethoxydiphenyl borate inhibits the reaction [[TNF protein co-treated with IFNG protein] promotes the reaction [Diclofenac results in increased activity of CASP3 protein]]; [Diclofenac co-treated with IFNG protein] results in increased phosphorylation of STAT1 protein; [TNF protein co-treated with IFNG protein] promotes the reaction [Diclofenac affects the abundance of Calcium]; [TNF protein co-treated with IFNG protein] promotes the reaction [Diclofenac results in increased activity of CASP3 protein]; Calcium promotes the reaction [[Diclofenac co-treated with IFNG protein] results in increased phosphorylation of STAT1 protein]; IFNG protein promotes the reaction [Diclofenac results in increased activity of CASP3 protein]; pyrazolanthrone inhibits the reaction [[Diclofenac co-treated with IFNG protein] results in increased phosphorylation of STAT1 protein] Diclofenac results in decreased expression of IFNG mRNA |
CTD |
PMID:19393675 PMID:22285467 PMID:23395999 PMID:23939143 PMID:26609140 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IFRD1 |
interferon related developmental regulator 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of IFRD1 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017
|
|
G |
IGF1R |
insulin like growth factor 1 receptor |
affects expression |
EXP |
Diclofenac affects the expression of IGF1R mRNA |
CTD |
PMID:24752500 |
|
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
|
|
G |
IGF2R |
insulin like growth factor 2 receptor |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of IGF2R mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 6:159,969,082...160,111,504
Ensembl chr 6:159,969,082...160,113,507
|
|
G |
IGFBP1 |
insulin like growth factor binding protein 1 |
affects expression increases expression |
EXP ISO |
Diclofenac affects the expression of IGFBP1 mRNA Diclofenac results in increased expression of IGFBP1 mRNA |
CTD |
PMID:24752500 PMID:26934552 |
|
NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660
|
|
G |
IGFBP2 |
insulin like growth factor binding protein 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of IGFBP2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 2:216,632,828...216,664,436
Ensembl chr 2:216,632,828...216,664,436
|
|
G |
IGFBP3 |
insulin like growth factor binding protein 3 |
affects expression |
EXP |
Diclofenac affects the expression of IGFBP3 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
Diclofenac inhibits the reaction [Freund's Adjuvant results in increased phosphorylation of IKBKB protein] |
CTD |
PMID:25935278 |
|
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
|
|
G |
IKBKE |
inhibitor of nuclear factor kappa B kinase subunit epsilon |
increases expression |
ISO |
Diclofenac results in increased expression of IKBKE mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:206,470,476...206,496,889
Ensembl chr 1:206,470,476...206,496,889
|
|
G |
IKBKG |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
affects expression |
EXP |
Diclofenac affects the expression of IKBKG mRNA |
CTD |
PMID:24752500 |
|
NCBI chr X:154,541,238...154,565,046
Ensembl chr X:154,541,199...154,565,046
|
|
G |
IL10 |
interleukin 10 |
increases response to substance multiple interactions |
EXP ISO |
IL10 gene polymorphism results in increased susceptibility to Diclofenac [Gum Arabic co-treated with Water deficiency co-treated with Diclofenac] results in increased expression of IL10 protein; Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL10 protein] |
CTD |
PMID:15122773 PMID:23939143 PMID:31042592 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL12RB1 |
interleukin 12 receptor subunit beta 1 |
increases expression |
ISO |
Diclofenac results in increased expression of IL12RB1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr19:18,058,995...18,098,816
Ensembl chr19:18,058,995...18,098,944
|
|
G |
IL13RA1 |
interleukin 13 receptor subunit alpha 1 |
increases expression |
ISO |
Diclofenac results in increased expression of IL13RA1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr X:118,727,606...118,805,228
Ensembl chr X:118,727,133...118,794,535
|
|
G |
IL16 |
interleukin 16 |
decreases expression |
ISO |
Diclofenac results in decreased expression of IL16 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
|
|
G |
IL17A |
interleukin 17A |
increases expression multiple interactions |
ISO |
Diclofenac results in increased expression of IL17A protein Diclofenac inhibits the reaction [Freund's Adjuvant results in increased expression of IL17A protein] |
CTD |
PMID:22285467 PMID:25450234 |
|
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL18 |
interleukin 18 |
multiple interactions increases expression |
ISO |
diacerein inhibits the reaction [Diclofenac results in increased expression of IL18 protein] |
CTD |
PMID:38582345 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
|
|
G |
IL18BP |
interleukin 18 binding protein |
increases expression |
ISO |
Diclofenac results in increased expression of IL18BP mRNA |
CTD |
PMID:26934552 |
|
NCBI chr11:71,998,909...72,008,200
Ensembl chr11:71,998,613...72,007,315
|
|
G |
IL1A |
interleukin 1 alpha |
multiple interactions increases expression |
EXP |
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Diclofenac Diclofenac results in increased expression of IL1A mRNA |
CTD |
PMID:19362101 PMID:32816093 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions increases expression |
EXP ISO |
Diclofenac inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] Diclofenac inhibits the reaction [Freund's Adjuvant results in increased expression of IL1B protein] Diclofenac results in increased expression of IL1B mRNA Diclofenac results in increased expression of IL1B mRNA; Diclofenac results in increased expression of IL1B protein 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Diclofenac promotes the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]]; [Water deficiency co-treated with Diclofenac] results in increased expression of IL1B protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Diclofenac promotes the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]]; diacerein inhibits the reaction [Diclofenac results in increased expression of IL1B protein]; Diclofenac inhibits the reaction [Freund's Adjuvant results in increased expression of IL1B protein]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in decreased expression of NFKBIA protein]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein]; Diclofenac promotes the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; Diclofenac promotes the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B mRNA]; Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B protein]; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of IL1B protein]; RELA mutant form inhibits the reaction [Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]]; SN50 peptide inhibits the reaction [Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] |
CTD |
PMID:15135310 PMID:15705740 PMID:19393675 PMID:22285467 PMID:23395999 PMID:23939143 PMID:24747151 PMID:25051504 PMID:25450234 PMID:25935278 PMID:28138970 PMID:29027214 PMID:31042592 PMID:31926916 PMID:32816093 PMID:38582345 More...
|
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1R1 |
interleukin 1 receptor type 1 |
affects expression increases expression |
EXP ISO |
Diclofenac affects the expression of IL1R1 mRNA Diclofenac results in increased expression of IL1R1 mRNA |
CTD |
PMID:24752500 PMID:26934552 |
|
NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874
|
|
G |
IL1R2 |
interleukin 1 receptor type 2 |
increases expression |
ISO |
Diclofenac results in increased expression of IL1R2 mRNA |
CTD |
PMID:26934552 PMID:30723492 |
|
NCBI chr 2:101,991,960...102,028,544
Ensembl chr 2:101,991,960...102,028,544
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
increases secretion decreases expression increases expression multiple interactions |
EXP ISO |
Diclofenac results in increased secretion of IL1RN protein Diclofenac results in decreased expression of IL1RN mRNA Diclofenac results in increased expression of IL1RN mRNA Lipopolysaccharides inhibits the reaction [Diclofenac results in increased secretion of IL1RN protein] |
CTD |
PMID:9491209 PMID:26934552 PMID:35537566 |
|
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
IL2 |
interleukin 2 |
multiple interactions |
EXP |
Diclofenac affects the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL2 protein] |
CTD |
PMID:29777833 |
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL23A |
interleukin 23 subunit alpha |
decreases expression |
EXP |
Diclofenac results in decreased expression of IL23A mRNA |
CTD |
PMID:19192274 |
|
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
|
|
G |
IL24 |
interleukin 24 |
increases expression |
EXP |
Diclofenac results in increased expression of IL24 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 1:206,897,443...206,904,139
Ensembl chr 1:206,897,443...206,904,139
|
|
G |
IL2RG |
interleukin 2 receptor subunit gamma |
increases expression |
ISO |
Diclofenac results in increased expression of IL2RG mRNA |
CTD |
PMID:26934552 |
|
NCBI chr X:71,107,404...71,111,577
Ensembl chr X:71,107,404...71,112,108
|
|
G |
IL33 |
interleukin 33 |
decreases expression increases expression |
ISO |
Diclofenac results in decreased expression of IL33 mRNA Diclofenac results in increased expression of IL33 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
|
|
G |
IL4 |
interleukin 4 |
increases response to substance |
EXP |
IL4 gene polymorphism results in increased susceptibility to Diclofenac |
CTD |
PMID:15122773 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL5 |
interleukin 5 |
multiple interactions |
EXP |
Diclofenac inhibits the reaction [nickel sulfate results in increased secretion of IL5 protein] |
CTD |
PMID:15663561 |
|
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
IL6 |
interleukin 6 |
multiple interactions increases expression decreases expression |
EXP ISO |
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Diclofenac; Diclofenac affects the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL6 protein]; Diclofenac inhibits the reaction [Mustard Gas results in increased secretion of IL6 protein]; lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [Diclofenac results in increased expression of IL6 protein] Diclofenac results in increased expression of IL6 mRNA Diclofenac results in decreased expression of IL6 mRNA; Diclofenac results in decreased expression of IL6 protein Diclofenac results in increased expression of IL6 mRNA; Diclofenac results in increased expression of IL6 protein Diclofenac inhibits the reaction [Carrageenan results in increased expression of IL6 protein]; Diclofenac inhibits the reaction [Freund's Adjuvant results in increased expression of IL6 protein]; Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]; Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 protein] |
CTD |
PMID:19192274 PMID:19362101 PMID:23506792 PMID:23939143 PMID:24412305 PMID:25450234 PMID:25935278 PMID:27671914 PMID:29777833 PMID:31048000 More...
|
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IMMT |
inner membrane mitochondrial protein |
affects expression |
ISO |
Diclofenac affects the expression of IMMT mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 2:86,143,936...86,195,462
Ensembl chr 2:86,143,932...86,195,472
|
|
G |
INHBB |
inhibin subunit beta B |
increases expression |
ISO |
Diclofenac results in increased expression of INHBB mRNA |
CTD |
PMID:26934552 PMID:30723492 |
|
NCBI chr 2:120,346,136...120,351,803
Ensembl chr 2:120,346,136...120,351,803
|
|
G |
INKA2 |
inka box actin regulator 2 |
increases expression |
ISO |
Diclofenac results in increased expression of FAM212B mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 1:111,722,064...111,755,797
Ensembl chr 1:111,680,630...111,755,824
|
|
G |
INMT |
indolethylamine N-methyltransferase |
decreases expression |
ISO |
Diclofenac results in decreased expression of INMT mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 7:30,752,135...30,757,602
Ensembl chr 7:30,697,985...30,757,602
|
|
G |
INSL3 |
insulin like 3 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of INSL3 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr19:17,816,512...17,821,519
Ensembl chr19:17,816,512...17,821,574
|
|
G |
INSL6 |
insulin like 6 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of INSL6 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 9:4,991,976...5,185,639
Ensembl chr 9:5,123,880...5,185,647
|
|
G |
INSR |
insulin receptor |
affects expression |
EXP |
Diclofenac affects the expression of INSR mRNA |
CTD |
PMID:24752500 |
|
NCBI chr19:7,112,265...7,294,414
Ensembl chr19:7,112,255...7,294,414
|
|
G |
IQCF1 |
IQ motif containing F1 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of IQCF1 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 3:51,894,876...51,903,353
Ensembl chr 3:51,894,876...51,903,353
|
|
G |
IRAK4 |
interleukin 1 receptor associated kinase 4 |
increases expression |
ISO |
Diclofenac results in increased expression of IRAK4 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:43,758,951...43,789,541
Ensembl chr12:43,758,944...43,798,307
|
|
G |
IRF7 |
interferon regulatory factor 7 |
decreases expression |
EXP |
Diclofenac results in decreased expression of IRF7 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983
|
|
G |
IRGM |
immunity related GTPase M |
increases expression |
ISO |
Diclofenac results in increased expression of IRGM1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:150,846,521...150,902,402
Ensembl chr 5:150,846,521...150,900,736
|
|
G |
IRS1 |
insulin receptor substrate 1 |
affects expression |
EXP ISO |
Diclofenac affects the expression of IRS1 mRNA |
CTD |
PMID:24752500 PMID:26934552 |
|
NCBI chr 2:226,731,312...226,799,820
Ensembl chr 2:226,731,312...226,799,820
|
|
G |
ISG15 |
ISG15 ubiquitin like modifier |
decreases expression |
EXP |
Diclofenac results in decreased expression of ISG15 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 1:1,013,497...1,014,540
Ensembl chr 1:1,001,138...1,014,540
|
|
G |
ISG20 |
interferon stimulated exonuclease gene 20 |
decreases expression |
EXP |
Diclofenac results in decreased expression of ISG20 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr15:88,635,632...88,656,483
Ensembl chr15:88,635,670...88,656,483
|
|
G |
ISYNA1 |
inositol-3-phosphate synthase 1 |
increases expression |
ISO |
Diclofenac results in increased expression of ISYNA1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr19:18,434,388...18,438,133
Ensembl chr19:18,434,388...18,438,167
|
|
G |
ITGA2 |
integrin subunit alpha 2 |
affects expression |
EXP |
Diclofenac affects the expression of ITGA2 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
|
|
G |
ITGAL |
integrin subunit alpha L |
increases expression |
ISO |
Diclofenac results in increased expression of ITGAL mRNA |
CTD |
PMID:26934552 |
|
NCBI chr16:30,472,742...30,523,185
Ensembl chr16:30,472,658...30,523,567
|
|
G |
ITGAM |
integrin subunit alpha M |
increases expression |
ISO |
Diclofenac results in increased expression of ITGAM mRNA |
CTD |
PMID:27671914 |
|
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
|
|
G |
ITGAX |
integrin subunit alpha X |
decreases expression |
ISO |
Diclofenac results in decreased expression of ITGAX mRNA |
CTD |
PMID:35537566 |
|
NCBI chr16:31,355,176...31,382,999
Ensembl chr16:31,355,134...31,382,999
|
|
G |
ITGB1 |
integrin subunit beta 1 |
affects expression |
EXP |
Diclofenac affects the expression of ITGB1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
|
|
G |
ITGB2 |
integrin subunit beta 2 |
increases expression |
ISO |
Diclofenac results in increased expression of ITGB2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
|
|
G |
ITGB3 |
integrin subunit beta 3 |
multiple interactions |
EXP |
Diclofenac inhibits the reaction [TNF protein results in increased expression of ITGB3 protein] |
CTD |
PMID:19691487 |
|
NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
|
|
G |
ITIH3 |
inter-alpha-trypsin inhibitor heavy chain 3 |
increases expression |
ISO |
Diclofenac results in increased expression of ITIH3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:52,794,796...52,808,797
Ensembl chr 3:52,794,768...52,808,799
|
|
G |
ITIH4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
increases expression |
ISO |
Diclofenac results in increased expression of ITIH4 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:52,812,962...52,830,672
Ensembl chr 3:52,812,962...52,830,688
|
|
G |
ITM2A |
integral membrane protein 2A |
increases expression |
EXP |
Diclofenac results in increased expression of ITM2A mRNA |
CTD |
PMID:17379860 |
|
NCBI chr X:79,360,384...79,367,334
Ensembl chr X:79,360,384...79,367,667
|
|
G |
JADE2 |
jade family PHD finger 2 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of JADE2 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 5:134,523,952...134,583,227
Ensembl chr 5:134,524,312...134,583,230
|
|
G |
JADE3 |
jade family PHD finger 3 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of JADE3 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr X:46,912,301...47,061,242
Ensembl chr X:46,912,276...47,061,242
|
|
G |
JDP2 |
Jun dimerization protein 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of JDP2 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr14:75,426,943...75,474,107
Ensembl chr14:75,427,716...75,474,111
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
affects expression increases expression |
EXP ISO |
Diclofenac affects the expression of JUN mRNA Diclofenac results in increased expression of JUN mRNA |
CTD |
PMID:24752500 PMID:26934552 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
JUNB |
JunB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of JUNB mRNA |
CTD |
PMID:37844793 |
|
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
|
|
G |
JUND |
JunD proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP ISO |
Diclofenac results in increased expression of JUND mRNA |
CTD |
PMID:19022234 |
|
NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622
|
|
G |
KAT6B |
lysine acetyltransferase 6B |
affects expression |
EXP |
Diclofenac affects the expression of KAT6B mRNA |
CTD |
PMID:24752500 |
|
NCBI chr10:74,824,936...75,032,624
Ensembl chr10:74,824,927...75,032,624
|
|
G |
KBTBD11 |
kelch repeat and BTB domain containing 11 |
increases expression |
ISO |
Diclofenac results in increased expression of KBTBD11 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 8:1,973,677...2,006,936
Ensembl chr 8:1,973,677...2,006,936
|
|
G |
KHDC3L |
KH domain containing 3 like, subcortical maternal complex member |
increases expression |
ISO |
Diclofenac results in increased expression of KHDC3 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 6:73,362,658...73,364,171
Ensembl chr 6:73,362,658...73,364,171
|
|
G |
KIF5C |
kinesin family member 5C |
increases expression |
ISO |
Diclofenac results in increased expression of KIF5C mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 2:148,875,227...149,026,759
Ensembl chr 2:148,875,227...149,026,759
|
|
G |
KIT |
KIT proto-oncogene, receptor tyrosine kinase |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of KIT mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
|
|
G |
KLF4 |
KLF transcription factor 4 |
decreases expression |
ISO |
Diclofenac results in decreased expression of KLF4 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 9:107,484,852...107,489,769
Ensembl chr 9:107,484,852...107,490,482
|
|
G |
KLHL33 |
kelch like family member 33 |
decreases expression |
ISO |
Diclofenac results in decreased expression of KLHL33 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr14:20,425,852...20,436,166
Ensembl chr14:20,425,852...20,436,166
|
|
G |
KLK1 |
kallikrein 1 |
increases expression |
ISO |
Diclofenac results in increased expression of KLK1 protein |
CTD |
PMID:23506792 |
|
NCBI chr19:50,819,146...50,823,787
Ensembl chr19:50,819,146...50,823,787
|
|
G |
KNDC1 |
kinase non-catalytic C-lobe domain containing 1 |
increases expression |
ISO |
Diclofenac results in increased expression of KNDC1 mRNA |
CTD |
PMID:30723492 |
|
NCBI chr10:133,160,219...133,226,412
Ensembl chr10:133,160,219...133,226,412
|
|
G |
KNG1 |
kininogen 1 |
multiple interactions increases expression |
ISO |
[Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of KNG1 protein; lipopolysaccharide, E coli O55-B5 promotes the reaction [Diclofenac results in increased expression of KNG1 protein] |
CTD |
PMID:25772430 |
|
NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410
|
|
G |
KRAS |
KRAS proto-oncogene, GTPase |
affects expression |
EXP |
Diclofenac affects the expression of KRAS mRNA |
CTD |
PMID:24752500 |
|
NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
|
|
G |
LAX1 |
lymphocyte transmembrane adaptor 1 |
decreases expression |
ISO |
Diclofenac results in decreased expression of LAX1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:203,765,183...203,776,372
Ensembl chr 1:203,765,177...203,778,175
|
|
G |
LBP |
lipopolysaccharide binding protein |
increases expression affects expression decreases expression |
ISO |
Diclofenac results in increased expression of LBP protein Diclofenac affects the expression of LBP mRNA Diclofenac results in decreased expression of LBP mRNA |
CTD |
PMID:26934552 |
|
NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,013
|
|
G |
LCE1D |
late cornified envelope 1D |
decreases expression |
ISO |
Diclofenac results in decreased expression of LCE1D mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:152,796,721...152,798,181
Ensembl chr 1:152,796,721...152,798,181
|
|
G |
LCN2 |
lipocalin 2 |
increases expression increases secretion multiple interactions |
ISO |
Diclofenac results in increased expression of LCN2 mRNA Diclofenac results in increased secretion of LCN2 protein diacerein inhibits the reaction [Diclofenac results in increased secretion of LCN2 protein]; Diclofenac inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of LCN2 protein]; Diclofenac promotes the reaction [Buthionine Sulfoximine results in increased expression of LCN2 mRNA] |
CTD |
PMID:23939143 PMID:26934552 PMID:38582345 |
|
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
|
|
G |
LCP2 |
lymphocyte cytosolic protein 2 |
increases expression |
ISO |
Diclofenac results in increased expression of LCP2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:170,246,233...170,297,777
Ensembl chr 5:170,246,233...170,297,815
|
|
G |
LDHA |
lactate dehydrogenase A |
increases expression |
ISO |
Diclofenac results in increased expression of LDHA protein |
CTD |
PMID:25772430 |
|
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
|
|
G |
LEAP2 |
liver enriched antimicrobial peptide 2 |
increases expression |
ISO |
Diclofenac results in increased expression of LEAP2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:132,873,668...132,875,046
Ensembl chr 5:132,873,444...132,875,046
|
|
G |
LEPR |
leptin receptor |
affects expression increases expression |
ISO |
Diclofenac affects the expression of LEPR mRNA Diclofenac results in increased expression of LEPR protein |
CTD |
PMID:26934552 |
|
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
|
|
G |
LGALS3 |
galectin 3 |
increases expression |
ISO |
Diclofenac results in increased expression of LGALS3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
|
|
G |
LGMN |
legumain |
increases expression |
ISO |
Diclofenac results in increased expression of LGMN mRNA |
CTD |
PMID:26934552 |
|
NCBI chr14:92,703,809...92,748,627
Ensembl chr14:92,703,807...92,748,679
|
|
G |
LGR4 |
leucine rich repeat containing G protein-coupled receptor 4 |
increases expression |
ISO |
Diclofenac results in increased expression of LGR4 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr11:27,365,961...27,472,790
Ensembl chr11:27,365,961...27,472,790
|
|
G |
LHX2 |
LIM homeobox 2 |
decreases expression |
ISO |
Diclofenac results in decreased expression of LHX2 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 9:124,011,768...124,033,301
Ensembl chr 9:124,001,670...124,033,301
|
|
G |
LIFR |
LIF receptor subunit alpha |
decreases expression |
ISO |
Diclofenac results in decreased expression of LIFR mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:38,474,668...38,608,403
Ensembl chr 5:38,474,668...38,608,354
|
|
G |
LILRB3 |
leukocyte immunoglobulin like receptor B3 |
increases expression |
ISO |
Diclofenac results in increased expression of PIRB mRNA |
CTD |
PMID:26934552 PMID:30723492 |
|
NCBI chr19:54,216,278...54,223,007
Ensembl chr19:54,216,278...54,223,506
|
|
G |
LIPC |
lipase C, hepatic type |
decreases expression |
ISO |
Diclofenac results in decreased expression of LIPC mRNA |
CTD |
PMID:26934552 |
|
NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844
|
|
G |
LITAF |
lipopolysaccharide induced TNF factor |
increases expression |
ISO |
Diclofenac results in increased expression of LITAF mRNA |
CTD |
PMID:26934552 |
|
NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,546,875...11,636,381
|
|
G |
LMNB1 |
lamin B1 |
increases expression |
ISO |
Diclofenac results in increased expression of LMNB1 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 5:126,776,623...126,837,020
Ensembl chr 5:126,776,623...126,837,020
|
|
G |
LMO4 |
LIM domain only 4 |
decreases expression |
ISO |
Diclofenac results in decreased expression of LMO4 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 1:87,328,880...87,348,923
Ensembl chr 1:87,328,880...87,348,923
|
|
G |
LPAR4 |
lysophosphatidic acid receptor 4 |
decreases expression |
ISO |
Diclofenac results in decreased expression of LPAR4 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr X:78,747,720...78,758,714
Ensembl chr X:78,747,709...78,758,714
|
|
G |
LPL |
lipoprotein lipase |
increases expression |
ISO |
Diclofenac results in increased expression of LPL mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
|
|
G |
LRG1 |
leucine rich alpha-2-glycoprotein 1 |
increases expression |
ISO |
Diclofenac results in increased expression of LRG1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr19:4,536,402...4,540,036
Ensembl chr19:4,536,402...4,540,036
|
|
G |
LRP8 |
LDL receptor related protein 8 |
increases expression |
ISO |
Diclofenac results in increased expression of LRP8 mRNA |
CTD |
PMID:35537566 |
|
NCBI chr 1:53,242,364...53,328,070
Ensembl chr 1:53,242,364...53,328,469
|
|
G |
LTC4S |
leukotriene C4 synthase |
increases expression |
ISO |
Diclofenac results in increased expression of LTC4S mRNA |
CTD |
PMID:30723492 |
|
NCBI chr 5:179,793,986...179,796,647
Ensembl chr 5:179,793,980...179,796,647
|
|
G |
LXN |
latexin |
increases expression |
EXP |
Diclofenac results in increased expression of LXN mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 3:158,666,414...158,672,648
Ensembl chr 3:158,645,822...158,672,648
|
|
G |
LY6E |
lymphocyte antigen 6 family member E |
decreases expression increases expression |
EXP ISO |
Diclofenac results in decreased expression of LY6E mRNA Diclofenac results in increased expression of LY6E mRNA |
CTD |
PMID:19192274 PMID:26934552 |
|
NCBI chr 8:143,018,529...143,022,409
Ensembl chr 8:143,017,982...143,023,832
|
|
G |
LY75 |
lymphocyte antigen 75 |
increases expression |
ISO |
Diclofenac results in increased expression of LY75 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 2:159,803,355...159,904,756
Ensembl chr 2:159,803,355...159,904,756
|
|
G |
LYZ |
lysozyme |
increases expression |
ISO |
Diclofenac results in increased expression of LYZ2 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr12:69,348,381...69,354,234
Ensembl chr12:69,348,381...69,354,234
|
|
G |
MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
affects expression |
EXP |
Diclofenac affects the expression of MAGI1 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 3:65,353,526...66,038,918
Ensembl chr 3:65,353,525...66,038,918
|
|
G |
MALSU1 |
mitochondrial assembly of ribosomal large subunit 1 |
multiple interactions |
ISO |
[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MALSU1 mRNA |
CTD |
PMID:37844793 |
|
NCBI chr 7:23,299,339...23,311,729
Ensembl chr 7:23,298,739...23,311,729
|
|
G |
MAOA |
monoamine oxidase A |
affects expression |
EXP |
Diclofenac affects the expression of MAOA mRNA |
CTD |
PMID:24752500 |
|
NCBI chr X:43,655,006...43,746,817
Ensembl chr X:43,654,907...43,746,817
|
|
G |
MAOB |
monoamine oxidase B |
affects expression |
EXP |
Diclofenac affects the expression of MAOB mRNA |
CTD |
PMID:24752500 |
|
NCBI chr X:43,766,610...43,882,450
Ensembl chr X:43,766,610...43,882,450
|
|
G |
MAP2K3 |
mitogen-activated protein kinase kinase 3 |
affects expression |
EXP |
Diclofenac affects the expression of MAP2K3 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr17:21,284,711...21,315,240
Ensembl chr17:21,284,672...21,315,232
|
|
G |
MAP2K5 |
mitogen-activated protein kinase kinase 5 |
affects expression |
EXP |
Diclofenac affects the expression of MAP2K5 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr15:67,542,703...67,807,114
Ensembl chr15:67,542,703...67,807,117
|
|
G |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
affects expression |
EXP |
Diclofenac affects the expression of MAP2K6 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865
|
|
G |
MAP3K1 |
mitogen-activated protein kinase kinase kinase 1 |
increases expression |
ISO |
Diclofenac results in increased expression of MAP3K1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 5:56,815,549...56,896,152
Ensembl chr 5:56,815,549...56,896,152
|
|
G |
MAP3K12 |
mitogen-activated protein kinase kinase kinase 12 |
decreases expression |
ISO |
Diclofenac results in decreased expression of MAP3K12 mRNA |
CTD |
PMID:18172885 |
|
NCBI chr12:53,479,669...53,501,539
Ensembl chr12:53,479,669...53,500,063
|
|
G |
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7 |
affects expression |
EXP |
Diclofenac affects the expression of MAP3K7 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 6:90,513,579...90,587,072
Ensembl chr 6:90,513,573...90,587,086
|
|
G |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
affects expression |
EXP |
Diclofenac affects the expression of MAP4K4 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 2:101,697,707...101,894,690
Ensembl chr 2:101,696,850...101,894,690
|
|
G |
MAP7D1 |
MAP7 domain containing 1 |
increases expression |
ISO |
Diclofenac results in increased expression of MAP7D1 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 1:36,156,160...36,180,849
Ensembl chr 1:36,155,579...36,180,849
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Diclofenac results in increased phosphorylation of MAPK1 protein]; 2-aminoethoxydiphenyl borate inhibits the reaction [Diclofenac results in increased phosphorylation of MAPK1 protein]; Calcium promotes the reaction [Diclofenac results in increased phosphorylation of MAPK1 protein]; pyrazolanthrone inhibits the reaction [Diclofenac results in increased phosphorylation of MAPK1 protein] Diclofenac analog results in increased phosphorylation of MAPK1 protein; Diclofenac results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:24104198 PMID:26609140 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK13 |
mitogen-activated protein kinase 13 |
affects expression |
EXP |
Diclofenac affects the expression of MAPK13 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 6:36,130,513...36,144,521
Ensembl chr 6:36,127,809...36,144,524
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
affects expression |
EXP |
Diclofenac affects the expression of MAPK14 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,752...36,122,511
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Diclofenac results in increased phosphorylation of MAPK3 protein]; 2-aminoethoxydiphenyl borate inhibits the reaction [Diclofenac results in increased phosphorylation of MAPK3 protein]; Calcium promotes the reaction [Diclofenac results in increased phosphorylation of MAPK3 protein]; pyrazolanthrone inhibits the reaction [Diclofenac results in increased phosphorylation of MAPK3 protein] Diclofenac analog results in increased phosphorylation of MAPK3 protein; Diclofenac results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:24104198 PMID:26609140 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
affects expression |
EXP |
Diclofenac affects the expression of MAPK8 mRNA |
CTD |
PMID:24752500 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK8IP3 |
mitogen-activated protein kinase 8 interacting protein 3 |
increases expression |
ISO |
Diclofenac results in increased expression of MAPK8IP3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr16:1,706,195...1,770,351
Ensembl chr16:1,706,166...1,770,351
|
|
G |
MAPKAPK3 |
MAPK activated protein kinase 3 |
increases expression |
ISO |
Diclofenac results in increased expression of MAPKAPK3 mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 3:50,611,520...50,649,291
Ensembl chr 3:50,611,520...50,649,291
|
|
G |
MARCHF1 |
membrane associated ring-CH-type finger 1 |
increases expression |
ISO |
Diclofenac results in increased expression of MARCHF1 mRNA |
CTD |
PMID:26934552 PMID:35537566 |
|
NCBI chr 4:163,524,298...164,384,019
Ensembl chr 4:163,524,298...164,384,050
|
|
G |
MARCO |
macrophage receptor with collagenous structure |
increases expression decreases expression |
ISO |
Diclofenac results in increased expression of MARCO mRNA Diclofenac results in decreased expression of MARCO mRNA |
CTD |
PMID:26934552 |
|
NCBI chr 2:118,942,194...118,994,660
Ensembl chr 2:118,942,194...118,994,660
|
|
G |
MASTL |
microtubule associated serine/threonine kinase like |
decreases expression |
ISO |
Diclofenac results in decreased expression of MASTL mRNA |
CTD |
PMID:26934552 PMID:35537566 |
|
NCBI chr10:27,154,479...27,187,953
Ensembl chr10:27,154,824...27,187,953
|
|
G |
MBL1P |
mannose binding lectin 1, pseudogene |
increases expression |
ISO |
Diclofenac results in increased expression of MBL1 mRNA |
CTD |
PMID:26934552 |
|
| |